MEpedia - Recent changes [en]

Venlafaxine

BeardedBaldy — Sat, 14 Nov 2026 09:45:34 GMT

Added authorlinks in reference.

← Older revision		Revision as of 09:45, November 14, 2026
Line 4:		Line 4:
	==Venlafaxine and pain==		==Venlafaxine and pain==
	[[File:Venlafaxine.png\|alt=Box of generic venlafaxine capsules\|thumb\|right\|Venlafaxine]]		[[File:Venlafaxine.png\|alt=Box of generic venlafaxine capsules\|thumb\|right\|Venlafaxine]]
	Venlafaxine has been investigated for use for treating [[nerve pain]] (neuropathic pain) in people without depression, but evidence is generally weak.<ref name="vlfpain27837032">{{Cite journal \| last = Aiyer \| first = Rohit \| last2 = Barkin \| first2 = Robert L. \| last3 = Bhatia \| first3 = Anurag \| date = 2017-10-01 \| title = Treatment of Neuropathic Pain with Venlafaxine: A Systematic Review \| url = https://www.ncbi.nlm.nih.gov/m/pubmed/27837032/\|journal=Pain Medicine (Malden, Mass.)\|volume=18\|issue=10\|pages=1999–2012\|doi=10.1093/pm/pnw261\|issn=1526-4637\|pmid=27837032}}</ref>{{Clear}}		Venlafaxine has been investigated for use for treating [[nerve pain]] (neuropathic pain) in people without depression, but evidence is generally weak.<ref name="vlfpain27837032">{{Cite journal \| last = Aiyer \| first = Rohit \| authorlink = Rohit Aiyer \| last2 = Barkin \| first2 = Robert L. \| authorlink2 = Robert Barkin \| last3 = Bhatia \| first3 = Anurag \| authorlink3 = Anurag Bhatia \| date = 2017-10-01 \| title = Treatment of Neuropathic Pain with Venlafaxine: A Systematic Review \| url = https://www.ncbi.nlm.nih.gov/m/pubmed/27837032/\|journal=Pain Medicine (Malden, Mass.)\|volume=18\|issue=10\|pages=1999–2012\|doi=10.1093/pm/pnw261\|issn=1526-4637\|pmid=27837032}}</ref>{{Clear}}

	==See also ==		==See also ==

Yvette Cooper

BeardedBaldy — Sat, 14 Nov 2026 09:42:39 GMT

Added authorlinks in references.

← Older revision		Revision as of 09:42, November 14, 2026
Line 1:		Line 1:
	{{NeedsImage}}		{{NeedsImage}}
	'''Yvette Cooper''' is a [[United Kingdom\|British]] politician and has been a Labour party MP for Normanton, Pontefract and Castleford since 1997.<ref>{{Cite web\|url=https://www.theyworkforyou.com/mp/10131/yvette_cooper/normanton,_pontefract_and_castleford \| title = Yvette Cooper MP, Normanton, Pontefract and Castleford - TheyWorkForYou\|website=TheyWorkForYou\|language=en\|access-date=2018-11-23}}</ref> She has spoken about suffering from [[Myalgic encephalomyelitis\|Myalgic Encephalomyelitis]], which began when she was 24, and lasted three years.<ref>{{Cite news \| url=https://www.telegraph.co.uk/culture/hay-festival/8557386/Hay-festival-Yvette-Cooper-talks-of-battle-with-ME.html \| title = Hay festival: Yvette Cooper talks of battle with ME \| last =Gordon \| first=Bryony \| date = 2011-06-05\|access-date=2018-11-23\|language=en-GB\|issn=0307-1235}}</ref><ref>{{Cite news \| url=https://www.independent.co.uk/incoming/tired-of-all-this-miserable-me-stuff-5597991.html \| title = Tired of all this miserable ME stuff \| last =Cooper \| first=Yvette \| date = Oct 4, 1996\|work=The Independent\|access-date=2018-11-23\|archive-url=\|archive-date=\|url-status=\|language=en-GB}}</ref> Despite this when she was the Secretary of State for Work and Pensions she agreed to a harsher benefits regime.<ref>{{Cite web\|url=https://www.benefitsandwork.co.uk/news/1207-even-harsher-new-esa-medical-approved \| title = Even harsher new ESA medical approved \| last =Donnison \| first = Steve \| author-link =\| date = \|website=Benefits and Work\|language=en\|archive-url=\|archive-date=\|url-status=\|access-date=2021-11-20}}</ref>		'''Yvette Cooper''' is a [[United Kingdom\|British]] politician and has been a Labour party MP for Normanton, Pontefract and Castleford since 1997.<ref>{{Cite web\|url=https://www.theyworkforyou.com/mp/10131/yvette_cooper/normanton,_pontefract_and_castleford \| title = Yvette Cooper MP, Normanton, Pontefract and Castleford - TheyWorkForYou\|website=TheyWorkForYou\|language=en\|access-date=2018-11-23}}</ref> She has spoken about suffering from [[Myalgic encephalomyelitis\|Myalgic Encephalomyelitis]], which began when she was 24, and lasted three years.<ref>{{Cite news \| url=https://www.telegraph.co.uk/culture/hay-festival/8557386/Hay-festival-Yvette-Cooper-talks-of-battle-with-ME.html \| title = Hay festival: Yvette Cooper talks of battle with ME \| last =Gordon \| first=Bryony \| authorlink = Bryony Gordon \| date = 2011-06-05\|access-date=2018-11-23\|language=en-GB\|issn=0307-1235}}</ref><ref>{{Cite news \| url=https://www.independent.co.uk/incoming/tired-of-all-this-miserable-me-stuff-5597991.html \| title = Tired of all this miserable ME stuff \| last =Cooper \| first=Yvette \| authorlink = Yvette Cooper \| date = Oct 4, 1996\|work=The Independent\|access-date=2018-11-23\|archive-url=\|archive-date=\|url-status=\|language=en-GB}}</ref> Despite this when she was the Secretary of State for Work and Pensions she agreed to a harsher benefits regime.<ref>{{Cite web\|url=https://www.benefitsandwork.co.uk/news/1207-even-harsher-new-esa-medical-approved \| title = Even harsher new ESA medical approved \| last =Donnison \| first = Steve \| author-link = Steve Donnison \| date = \|website=Benefits and Work\|language=en\|archive-url=\|archive-date=\|url-status=\|access-date=2021-11-20}}</ref>

	==Talks and interviews==		==Talks and interviews==

Ozone

BeardedBaldy — Sat, 14 Nov 2026 09:39:53 GMT

Added authorlinks in references.

← Older revision		Revision as of 09:39, November 14, 2026
Line 3:		Line 3:

	== Notable studies ==		== Notable studies ==
	* 2018, Oxygen-Ozone therapy is a potentially effective therapy in [[Chronic fatigue syndrome\|Chronic Fatigue Syndrome]]: Results of an Italian study in 65 patients<ref name="Tirelli2018">{{Cite journal \| last = Tirelli \| first = Umberto \| author-link =Umberto Tirelli \| last2 = Cirrito \| first2 = Cinzia \| last3 = Pavanello \| first3 = Martina \| last4 = Lleshi \| first4 = Arben \| last5 = Franzini \| first5 = Marianno \| date = 2018-07-25 \| title = Ozone therapy is an effective therapy in chronic fatigue syndrome: result of an Italian study in 65 patients.\|url=https://wwjournals.com/index.php/gjra/article/view/4800/0\|journal=GLOBAL JOURNAL FOR RESEARCH ANALYSIS\|language=en\|volume=7\|issue=5\|pages=\|via=}}</ref> - [https://wwjournals.com/index.php/gjra/article/view/4800/0 (Abstract)]		* 2018, Oxygen-Ozone therapy is a potentially effective therapy in [[Chronic fatigue syndrome\|Chronic Fatigue Syndrome]]: Results of an Italian study in 65 patients<ref name="Tirelli2018">{{Cite journal \| last = Tirelli \| first = Umberto \| author-link = Umberto Tirelli \| last2 = Cirrito \| first2 = Cinzia \| authorlink2 = Ciniza Cirrito \| last3 = Pavanello \| first3 = Martina \| authorlink3 = Martina Pavanello \| last4 = Lleshi \| first4 = Arben \| authorlink4 = Arben Lleshi \| last5 = Franzini \| first5 = Marianno \| authorlink5 = Marianno Franzini \| date = 2018-07-25 \| title = Ozone therapy is an effective therapy in chronic fatigue syndrome: result of an Italian study in 65 patients.\|url=https://wwjournals.com/index.php/gjra/article/view/4800/0\|journal=GLOBAL JOURNAL FOR RESEARCH ANALYSIS\|language=en\|volume=7\|issue=5\|pages=\|via=}}</ref> - [https://wwjournals.com/index.php/gjra/article/view/4800/0 (Abstract)]
	*2022, Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Greatly Improved Fatigue Symptoms When Treated with Oxygen-Ozone Autohemotherapy<ref name="Tirelli2022">{{Cite journal \| title = Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Greatly Improved Fatigue Symptoms When Treated with Oxygen-Ozone Autohemotherapy \| date = Jan 2022\|url=https://www.mdpi.com/2077-0383/11/1/29/htm\|journal=Journal of Clinical Medicine\|volume=11\|issue=1\|pages=29 \| last = Tirelli \| first = Umberto \| author-link =Umberto Tirelli \| last2 = Franzini \| first2 = Marianno \| authorlink2 = \| last3 = Valdenassi \| first3 = Luigi \| authorlink3 = \| last4 = Pandolfi \| first4 = Sergio \| authorlink4 = \| last5 = Berretta \| first5 = Massimiliano \| authorlink5 = \| last6 = Ricevuti \| first6 = Giovanni \| authorlink6 = \| last7 = Chirumbolo \| first7 = Salvatore\|language=en\|doi=10.3390/jcm11010029\|pmc=PMC8745272\|pmid=35011770\|access-date=\|quote=\|via=}}</ref> - [https://www.mdpi.com/2077-0383/11/1/29/htm (Full text)]		*2022, Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Greatly Improved Fatigue Symptoms When Treated with Oxygen-Ozone Autohemotherapy<ref name="Tirelli2022">{{Cite journal \| title = Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Greatly Improved Fatigue Symptoms When Treated with Oxygen-Ozone Autohemotherapy \| date = Jan 2022\|url=https://www.mdpi.com/2077-0383/11/1/29/htm\|journal=Journal of Clinical Medicine\|volume=11\|issue=1\|pages=29 \| last = Tirelli \| first = Umberto \| author-link =Umberto Tirelli \| last2 = Franzini \| first2 = Marianno \| authorlink2 = Marianno Franzini \| last3 = Valdenassi \| first3 = Luigi \| authorlink3 = Luigi Valenassi \| last4 = Pandolfi \| first4 = Sergio \| authorlink4 = Sergio Pandolfi \| last5 = Berretta \| first5 = Massimiliano \| authorlink5 = Massimiliano Berretta \| last6 = Ricevuti \| first6 = Giovanni \| authorlink6 = Giovanni Ricevuti \| last7 = Chirumbolo \| first7 = Salvatore \| authorlink7 = Salvatore Chirumbolo \| language=en\|doi=10.3390/jcm11010029\|pmc=PMC8745272\|pmid=35011770\|access-date=\|quote=\|via=}}</ref> - [https://www.mdpi.com/2077-0383/11/1/29/htm (Full text)]
	*This research was funded by SIOOT, Gorle (BG). A company selling ozone treat. This represents a significant conflict of interestment		*This research was funded by SIOOT, Gorle (BG). A company selling ozone treat. This represents a significant conflict of interestment

AIM ImmunoTech

BeardedBaldy — Sat, 14 Nov 2026 09:27:44 GMT

Added authorlinks in references.

← Older revision		Revision as of 09:27, November 14, 2026
Line 8:		Line 8:
	==Change in leadership==		==Change in leadership==

	In Feb 2016, Dr. [[William Carter]], then Chairman and CEO, was terminated by the board of directors of Hermispherx Biopharma, now AIM ImmunoTech, who cited that part of the reason was a strong financial austerity plan. William M. Mitchell, M.D., Ph.D. was promoted in house as his replacement.<ref>{{Cite news \|url =https://www.bizjournals.com/philadelphia/news/2016/02/19/philly-biotech-hemispherx-fires-ceo-william-carter.html \| title = Philadelphia biotech firm fires longtime chairman & CEO \| last = George \| first = John \| date = Feb 19, 2016\|work=Philadelphia Business Journal \| access-date = 2019-09-26\| archive-url = \| archive-date = \|url-status = \| quote=}}</ref>		In Feb 2016, Dr. [[William Carter]], then Chairman and CEO, was terminated by the board of directors of Hermispherx Biopharma, now AIM ImmunoTech, who cited that part of the reason was a strong financial austerity plan. William M. Mitchell, M.D., Ph.D. was promoted in house as his replacement.<ref>{{Cite news \|url =https://www.bizjournals.com/philadelphia/news/2016/02/19/philly-biotech-hemispherx-fires-ceo-william-carter.html \| title = Philadelphia biotech firm fires longtime chairman & CEO \| last = George \| first = John \| authorlink = John George \| date = Feb 19, 2016\|work=Philadelphia Business Journal \| access-date = 2019-09-26\| archive-url = \| archive-date = \|url-status = \| quote=}}</ref>

	In June 2016, the law suit was resolved between Dr. Carter and Hemispherx, now AIM ImmunoTech, regarding the wrongful termination claim. As part of the settlement, the intellectual property rights, including the patent for Ampligen and Alferon, are irrevocably assigned to to AIM ImmunoTech.<ref>{{Cite news \|url =https://www.bizjournals.com/philadelphia/news/2016/06/07/hemispherx-gets-ip-rights-from-fired-ceo-carter.html \| title = Hemispherx gets IP rights from the CEO it fired \| last = George \| first = John \| date = Jun 7, 2016\|work=Philadelphia Business Journal \| access-date = 2019-09-26\| archive-url = \| archive-date = \|url-status = \| quote=}}</ref>		In June 2016, the law suit was resolved between Dr. Carter and Hemispherx, now AIM ImmunoTech, regarding the wrongful termination claim. As part of the settlement, the intellectual property rights, including the patent for Ampligen and Alferon, are irrevocably assigned to to AIM ImmunoTech.<ref>{{Cite news \|url =https://www.bizjournals.com/philadelphia/news/2016/06/07/hemispherx-gets-ip-rights-from-fired-ceo-carter.html \| title = Hemispherx gets IP rights from the CEO it fired \| last = George \| first = John \| authorlink = John George \| date = Jun 7, 2016\|work=Philadelphia Business Journal \| access-date = 2019-09-26\| archive-url = \| archive-date = \|url-status = \| quote=}}</ref>

	==Management==		==Management==
Line 47:		Line 47:
	*http://simmaronresearch.com/2016/05/hemispherx-ampligen-approval-chronic-fatigue-syndrome-top-priority/		*http://simmaronresearch.com/2016/05/hemispherx-ampligen-approval-chronic-fatigue-syndrome-top-priority/
	*2014, [http://investorshub.advfn.com/boards/read_msg.aspx?message_id=96215994 Investor's post about HEB's rocky history]		*2014, [http://investorshub.advfn.com/boards/read_msg.aspx?message_id=96215994 Investor's post about HEB's rocky history]
	*2016, [https://www.benzinga.com/general/biotech/16/12/8851721/hemispherx-biopharma-ceo-explains-chronic-fatigue-syndrome-and-how-the Hemispherx BioPharma CEO Explains Chronic Fatigue Syndrome And How The Company Is Treating It]<ref>{{citation \| last = Hasse \| first = Javier \| date = Dec 30, 2016 \| title = Hemispherx BioPharma CEO Explains Chronic Fatigue Syndrome And How The Company Is Treating It\|url= https://www.benzinga.com/general/biotech/16/12/8851721/hemispherx-biopharma-ceo-explains-chronic-fatigue-syndrome-and-how-the\|newspaper= Benzinga\|location= Detroit Michigan\|access-date= }}</ref>		*2016, [https://www.benzinga.com/general/biotech/16/12/8851721/hemispherx-biopharma-ceo-explains-chronic-fatigue-syndrome-and-how-the Hemispherx BioPharma CEO Explains Chronic Fatigue Syndrome And How The Company Is Treating It]<ref>{{citation \| last = Hasse \| first = Javier \| authorlink = Javier Hasse \| date = Dec 30, 2016 \| title = Hemispherx BioPharma CEO Explains Chronic Fatigue Syndrome And How The Company Is Treating It\|url= https://www.benzinga.com/general/biotech/16/12/8851721/hemispherx-biopharma-ceo-explains-chronic-fatigue-syndrome-and-how-the\|newspaper= Benzinga\|location= Detroit Michigan\|access-date= }}</ref>
	*2016, [http://cdn2.hubspot.net/hubfs/150154/docs/Hemispherx-Executive-Informational-Overview-11-27-16.pdf?__hssc=75734090.1.1482434979170&__hstc=75734090.d484bcfed76166643c7e8f36a0c76637.1482434979170.1482434979170.1482434979170.1&__hsfp=4187238277&hsCtaTracking=afde00a7-b0f3-44d3-b072-5febf480affb%7Cb8ddd437-9009-4bb9-a8fe-65a376fff33f Executive Informational Overview by Crystal Research Associates]<ref name="Crystal, 2016" />		*2016, [http://cdn2.hubspot.net/hubfs/150154/docs/Hemispherx-Executive-Informational-Overview-11-27-16.pdf?__hssc=75734090.1.1482434979170&__hstc=75734090.d484bcfed76166643c7e8f36a0c76637.1482434979170.1482434979170.1482434979170.1&__hsfp=4187238277&hsCtaTracking=afde00a7-b0f3-44d3-b072-5febf480affb%7Cb8ddd437-9009-4bb9-a8fe-65a376fff33f Executive Informational Overview by Crystal Research Associates]<ref name="Crystal, 2016" />
	*2016, [http://www.streetinsider.com/Corporate+News/Hemispherx+Biopharma+%28HEB%29+Comments+on+Recent+Meeting+with+NIH+for+MECFS+Research+Advancement/11408291.html Hemispherx Biopharma (HEB) Comments on Recent Meeting with NIH for ME/CFS Research Advancement] (see also [[NIH Post-Infectious ME/CFS Study]])		*2016, [http://www.streetinsider.com/Corporate+News/Hemispherx+Biopharma+%28HEB%29+Comments+on+Recent+Meeting+with+NIH+for+MECFS+Research+Advancement/11408291.html Hemispherx Biopharma (HEB) Comments on Recent Meeting with NIH for ME/CFS Research Advancement] (see also [[NIH Post-Infectious ME/CFS Study]])

Workwell Foundation

BeardedBaldy — Sat, 14 Nov 2026 09:25:04 GMT

Added authorlink in reference.

← Older revision		Revision as of 09:25, November 14, 2026
Line 14:		Line 14:
	*2010, [http://ptjournal.apta.org/content/90/4/602.full Conceptual model for physical therapist management of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]<ref name="Davenport2010" />		*2010, [http://ptjournal.apta.org/content/90/4/602.full Conceptual model for physical therapist management of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]<ref name="Davenport2010" />
	*2005,[http://iv.iiarjournals.org/content/19/2/387.full.pdf Exercise capacity and immune function in male and female patients with Chronic Fatigue Syndrome (CFS)]<ref name="Snell2005" />		*2005,[http://iv.iiarjournals.org/content/19/2/387.full.pdf Exercise capacity and immune function in male and female patients with Chronic Fatigue Syndrome (CFS)]<ref name="Snell2005" />
	*2003, Subclassifying Chronic Fatigue Syndrome through Exercise Testing<ref name="VanNess2003">{{cite journal \| last=VanNess \| first=J. Mark \| authorlink = J. Mark VanNess \| last2 = Snell \| first2=Christopher R. \| authorlink2 = Christopher Snell \| last3 = Strayer \| first3=David R. \| authorlink3= David Strayer \| last4 = Dempsey \| first4 = Line \| author-link4 = \| last5 = Stevens \| first5 = Staci R. \| authorlink5 = Staci Stevens \| title=Subclassifying Chronic Fatigue Syndrome through Exercise Testing \| url = https://doi.org/10.1249%2F01.mss.0000069510.58763.e8 \|journal=Medicine & Science in Sports & Exercise \| volume=35 \| issue=6 \| year=2003 \| issn=0195-9131 \| doi=10.1249/01.mss.0000069510.58763.e8 \| pages=908–913}}</ref>		*2003, Subclassifying Chronic Fatigue Syndrome through Exercise Testing<ref name="VanNess2003">{{cite journal \| last=VanNess \| first=J. Mark \| authorlink = J. Mark VanNess \| last2 = Snell \| first2=Christopher R. \| authorlink2 = Christopher Snell \| last3 = Strayer \| first3=David R. \| authorlink3= David Strayer \| last4 = Dempsey \| first4 = Line \| author-link4 = Line Dempsey \| last5 = Stevens \| first5 = Staci R. \| authorlink5 = Staci Stevens \| title=Subclassifying Chronic Fatigue Syndrome through Exercise Testing \| url = https://doi.org/10.1249%2F01.mss.0000069510.58763.e8 \|journal=Medicine & Science in Sports & Exercise \| volume=35 \| issue=6 \| year=2003 \| issn=0195-9131 \| doi=10.1249/01.mss.0000069510.58763.e8 \| pages=908–913}}</ref>

	==Exercise recommendations for [[ME/CFS]]==		==Exercise recommendations for [[ME/CFS]]==

Journal of Chronic Fatigue Syndrome: Volume 13, Issue 2-3, 2006

BeardedBaldy — Sat, 14 Nov 2026 09:21:41 GMT

Added authorlinks in reference.

← Older revision		Revision as of 09:21, November 14, 2026
Line 18:		Line 18:
	<ref name="JasonL2006paed">{{citation \| last1 = Jason \| first1 = Leonard A \| authorlink1 = Leonard Jason \| last2 =Jordan \| first2 = Karen \| authorlink2 = Karen Jordan \| last3 =Miike \| first3 = Teruhisa \| authorlink3 = Teruhisa Miike \| last4 = Bell \| first4 = David S \| authorlink4 = David Bell \| last5 = Lapp \| first5 = Charles \| author-link5 = Charles Lapp \| last6 = Torres-Harding \| first6 = Susan \| authorlink6 = Susan Torres-Harding \| last7 =Rowe \| first7 = Kathy \| authorlink7 = Kathy Rowe \| last8 = Gurwitt \| first8 = Alan \| authorlink8 = Alan Gurwitt \| last9 = De Meirleir \| first9 = Kenny \| authorlink9 = Kenny de Meirleir \| last10 = Van Hoof \| first10 = Elke LS \| authorlink10 = Elke Van Hoof \| title = A Pediatric Case Definition for Myalgic Encephalomyelitis and Chronic Fatigue Syndrome \| journal =Journal of Chronic Fatigue Syndrome \| volume = 13 \| issue = 2-3 \| pages = 1-44 \| date = 2006 \| doi = 10.1300/J092v13n02_01 }}</ref>		<ref name="JasonL2006paed">{{citation \| last1 = Jason \| first1 = Leonard A \| authorlink1 = Leonard Jason \| last2 =Jordan \| first2 = Karen \| authorlink2 = Karen Jordan \| last3 =Miike \| first3 = Teruhisa \| authorlink3 = Teruhisa Miike \| last4 = Bell \| first4 = David S \| authorlink4 = David Bell \| last5 = Lapp \| first5 = Charles \| author-link5 = Charles Lapp \| last6 = Torres-Harding \| first6 = Susan \| authorlink6 = Susan Torres-Harding \| last7 =Rowe \| first7 = Kathy \| authorlink7 = Kathy Rowe \| last8 = Gurwitt \| first8 = Alan \| authorlink8 = Alan Gurwitt \| last9 = De Meirleir \| first9 = Kenny \| authorlink9 = Kenny de Meirleir \| last10 = Van Hoof \| first10 = Elke LS \| authorlink10 = Elke Van Hoof \| title = A Pediatric Case Definition for Myalgic Encephalomyelitis and Chronic Fatigue Syndrome \| journal =Journal of Chronic Fatigue Syndrome \| volume = 13 \| issue = 2-3 \| pages = 1-44 \| date = 2006 \| doi = 10.1300/J092v13n02_01 }}</ref>
	<ref name=" Oleske, 2006">		<ref name=" Oleske, 2006">
	{{Citation \| last1 = Oleske \| first1 = James M. \| authorlink1 = James Oleske \| last2 =Friedman \| first2 = Kenneth J. \| authorlink2 = Kenneth Friedman \| last3 = Kaufman \| first3 = Kenneth R. \| authorlink3 = \| last4 = Palumbo \| first4 = Donna \| authorlink4 = \| last5 = Sterling \| first5 = Jonathan \| authorlink5 = \| last6 =Evans \| first6 = Terri Lynn \| authorlink6 = \| title = Chronic Fatigue Syndrome in Children and Adolescents \| journal =Journal of Chronic Fatigue Syndrome \| volume = 13 \| issue = 2-3 \| page = \| date = 2006 \| pmid = \| doi = 10.1300/J092v13n02_07 }}</ref>		{{Citation \| last1 = Oleske \| first1 = James M. \| authorlink1 = James Oleske \| last2 =Friedman \| first2 = Kenneth J. \| authorlink2 = Kenneth Friedman \| last3 = Kaufman \| first3 = Kenneth R. \| authorlink3 = Kenneth Kaufman \| last4 = Palumbo \| first4 = Donna \| authorlink4 = Donna Palumbo \| last5 = Sterling \| first5 = Jonathan \| authorlink5 = Jonathan Sterling \| last6 = Evans \| first6 = Terri Lynn \| authorlink6 = Terri Evans \| title = Chronic Fatigue Syndrome in Children and Adolescents \| journal =Journal of Chronic Fatigue Syndrome \| volume = 13 \| issue = 2-3 \| page = \| date = 2006 \| pmid = \| doi = 10.1300/J092v13n02_07 }}</ref>
	</references>		</references>


	[[Category:Journal issues]][[Category:Journal of Chronic Fatigue Syndrome issues]]		[[Category:Journal issues]][[Category:Journal of Chronic Fatigue Syndrome issues]]

Template:Infobox book

BeardedBaldy — Sat, 14 Nov 2026 02:06:34 GMT

Undo revision 246752 by BeardedBaldy (talk) I didn't make changes that worked as I intended, so reverting back earlier version.

← Older revision		Revision as of 02:06, November 14, 2026
(4 intermediate revisions by the same user not shown)
Line 237:		Line 237:
	"isbn2": {		"isbn2": {
	"label": "Additional ISBN",		"label": "Additional ISBN",
	"aliases": [ "isbn-10",		"aliases": [
	"isbn13",		"isbn-10",
	"isbn-13"		"isbn13",
	],		"isbn-13"
			],
	"type": "string",		"type": "string",
	"description": "ISBN format: \"1-234-56789-0\" (prefer 1st edition)",		"description": "ISBN format: \"1-234-56789-0\" (prefer 1st edition)",
Line 360:		Line 361:
	"notes": {},		"notes": {},
	"note": {}		"note": {}
	},		},
	"format": "block",		"format": "block",
	"paramOrder": [		"paramOrder": [
Line 368:		Line 369:
	"pub_date",		"pub_date",
	"isbn",		"isbn",
	"isbn2",		"isbn2",
	"image",		"image",
	"caption",		"caption",

Svenska:Indien

BeardedBaldy — Sat, 14 Nov 2026 00:12:55 GMT

Translate to swedish.

New page

[[File:India_flag.svg.png|320px|right|thumb|'''Indien''']]

'''Indien''' är ett land i södra [[:Category:Asia|Asien]]

==Medicinska riktlinjer==

==Hälsomyndighet==

==Statlig sjukförsäkring==

==Privat sjukförsäkring==

==Tillgång till vård==

==Social säkerhet och handikappförmåner==

==Patientvälgörenheter==

==Forskning==
* 2019, Chronic fatigue syndrome: identification of transcription factor (TFs) associated with gene expression for drug signature prediction (Kroniskt trötthetssyndrom: identifikation av transkriptionsfaktor (TFer) associerad med genuttryck för medicin signatur förutsägelse)<ref>{{Cite journal | last = Choudhari | first = Jyoti Kant | authorlink = Jyoti Choudhari | last2 = Verma | first2 = Mukesh Kumar | authorlink2 = Mukesh Verma | last3 = Sahariah | first3 = Biju Prava | authorlink3 = Biju Sahariah | date = Dec 2019 | title = Chronic fatigue syndrome: identification of transcription factor (TFs) associated with gene expression for drug signature prediction | url =http://link.springer.com/10.1007/s13721-019-0203-7|journal=Network Modeling Analysis in Health Informatics and Bioinformatics|language=en|volume=8|issue=1 | pages = 23|doi=10.1007/s13721-019-0203-7|issn=2192-6662|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://link.springer.com/article/10.1007/s13721-019-0203-7 (Abstract)]

==Forskningsgrupper==

==Forskare==

==Kliniker==

==Nämnvärda patienter==

==Avlidna patienter==

==Vidare läsning==

==Se även==
*[[Ayurvedic medicine|Ayurvedisk medicin]]
*[[Alternative medicine|Alternativmedicin]]
*[[Bhupesh Prusty]]

==Referenser==
{{reflist}}
[[Category:Countries]]
[[Category:Asia]]
[[Category:India]]
[[Category:Swedish-language articles]]

India

BeardedBaldy — Sat, 14 Nov 2026 00:04:10 GMT

Added internal link to "Asia" category.

← Older revision		Revision as of 00:04, November 14, 2026
(4 intermediate revisions by the same user not shown)
Line 1:		Line 1:
			{{Language links
			\|page_sv=Indien
			}}
	[[File:India_flag.svg.png\|320px\|right\|thumb\|'''India''']]		[[File:India_flag.svg.png\|320px\|right\|thumb\|'''India''']]

	'''India''' is a country in South Asia.		'''India''' is a country in South [[:Category:Asia\|Asia]].

	==Medical guidelines==		==Medical guidelines==
Line 18:		Line 21:

	==Research==		==Research==
	* 2019, Chronic fatigue syndrome: identification of transcription factor (TFs) associated with gene expression for drug signature prediction<ref>{{Cite journal \| last = Choudhari \| first = Jyoti Kant \| authorlink = \| last2 = Verma \| first2 = Mukesh Kumar \| authorlink2 = \| last3 = Sahariah \| first3 = Biju Prava \| authorlink3 = \| date = Dec 2019 \| title = Chronic fatigue syndrome: identification of transcription factor (TFs) associated with gene expression for drug signature prediction \| url =http://link.springer.com/10.1007/s13721-019-0203-7\|journal=Network Modeling Analysis in Health Informatics and Bioinformatics\|language=en\|volume=8\|issue=1 \| pages = 23\|doi=10.1007/s13721-019-0203-7\|issn=2192-6662\|pmc=\|pmid=\|access-date=\|quote=\|via=}}</ref> - [https://link.springer.com/article/10.1007/s13721-019-0203-7 (Abstract)]		* 2019, Chronic fatigue syndrome: identification of transcription factor (TFs) associated with gene expression for drug signature prediction<ref>{{Cite journal \| last = Choudhari \| first = Jyoti Kant \| authorlink = Jyoti Choudhari \| last2 = Verma \| first2 = Mukesh Kumar \| authorlink2 = Mukesh Verma \| last3 = Sahariah \| first3 = Biju Prava \| authorlink3 = Biju Sahariah \| date = Dec 2019 \| title = Chronic fatigue syndrome: identification of transcription factor (TFs) associated with gene expression for drug signature prediction \| url =http://link.springer.com/10.1007/s13721-019-0203-7\|journal=Network Modeling Analysis in Health Informatics and Bioinformatics\|language=en\|volume=8\|issue=1 \| pages = 23\|doi=10.1007/s13721-019-0203-7\|issn=2192-6662\|pmc=\|pmid=\|access-date=\|quote=\|via=}}</ref> - [https://link.springer.com/article/10.1007/s13721-019-0203-7 (Abstract)]

	==Research groups==		==Research groups==
Line 35:		Line 38:
	*[[Ayurvedic medicine]]		*[[Ayurvedic medicine]]
	*[[Alternative medicine]]		*[[Alternative medicine]]
	*[[~~Bupesh~~ Prusty]]		*[[Bhupesh Prusty]]

	==References==		==References==
Line 42:		Line 45:
	[[Category:Asia]]		[[Category:Asia]]
	[[Category:India]]		[[Category:India]]
			[[Category:Multilingual pages]]

Svenska:Myalgisk encefalomyelit

BeardedBaldy — Fri, 13 Nov 2026 23:34:47 GMT

Relocate lang links.

← Older revision		Revision as of 23:34, November 13, 2026
Line 61:		Line 61:
	{{Main article \|page_name =Onset of ME/CFS}}		{{Main article \|page_name =Onset of ME/CFS}}

	Enligt Dr [[Byron Hyde]], efter en inkubationstid av 4 till 7 dagar, medför generellt prodromalfasen en [[sv:Influensaliknande sjukdom\|influensaliknande sjukdom]] med [[~~low-grade fever~~\|låggradig feber]].<ref name="Evans2018" /> I de flesta, men inte alla, fall är en [[infection\|infektion]] eller infektionsprocess uppenbar.<ref name="Evans2018">{{Cite journal \| last = Evans \| first = Meredyth \| authorlink = Meredyth Evans \| last2 = Jason \| first2 =Leonard \| authorlink2 = Leonard Jason \| date = 2018 \| title = Onset patterns of chronic fatigue syndrome and myalgic encephalomyelitis\|url=https://www.openaccessjournals.com/articles/Onset%20patterns%20of%20chronic%20fatigue%20syndrome%20and%20myalgic%20encephalomyelitis.pdf \| journal=Research on Chronic diseases\|volume=2\|issue=1\|pages=2-3\|quote=\|via=}}</ref> Två till sju dagar senare, påbörjas en kronisk fas, kännetecknad av en mätbar oklar förändring i funktionen av det centrala nervsystemet. Det är denna andra, ihållande fas som mest kännetecknar ME.<ref name="Nightingale">{{Citation \| title = The Nightingale Research Foundation Definition of Myalgic Encephalomyelitis (M.E.)\|pages=\|language=en\|title-link=Nightingale Research Foundation definition \| date = 2016 \| publisher=IACFS/ME \| last = Hyde \| first = Byron \| authorlink = Byron Hyde\|others=\|oclc=\|quote=\|location=}}</ref><ref name="Evans2018" />		Enligt Dr [[Byron Hyde]], efter en inkubationstid av 4 till 7 dagar, medför generellt prodromalfasen en [[sv:Influensaliknande sjukdom\|influensaliknande sjukdom]] med [[sv:låggradig feber\|låggradig feber]].<ref name="Evans2018" /> I de flesta, men inte alla, fall är en [[infection\|infektion]] eller infektionsprocess uppenbar.<ref name="Evans2018">{{Cite journal \| last = Evans \| first = Meredyth \| authorlink = Meredyth Evans \| last2 = Jason \| first2 =Leonard \| authorlink2 = Leonard Jason \| date = 2018 \| title = Onset patterns of chronic fatigue syndrome and myalgic encephalomyelitis\|url=https://www.openaccessjournals.com/articles/Onset%20patterns%20of%20chronic%20fatigue%20syndrome%20and%20myalgic%20encephalomyelitis.pdf \| journal=Research on Chronic diseases\|volume=2\|issue=1\|pages=2-3\|quote=\|via=}}</ref> Två till sju dagar senare, påbörjas en kronisk fas, kännetecknad av en mätbar oklar förändring i funktionen av det centrala nervsystemet. Det är denna andra, ihållande fas som mest kännetecknar ME.<ref name="Nightingale">{{Citation \| title = The Nightingale Research Foundation Definition of Myalgic Encephalomyelitis (M.E.)\|pages=\|language=en\|title-link=Nightingale Research Foundation definition \| date = 2016 \| publisher=IACFS/ME \| last = Hyde \| first = Byron \| authorlink = Byron Hyde\|others=\|oclc=\|quote=\|location=}}</ref><ref name="Evans2018" />

	==Tecken och symptom==		==Tecken och symptom==
Line 72:		Line 72:
	* [[gastrointestinal\|gastrointestinala]] symptom		* [[gastrointestinal\|gastrointestinala]] symptom
	* [[headache\|huvudvärk]]		* [[headache\|huvudvärk]]
	*[[~~low-grade fever~~\|låggradig feber]], [[Temperature dysregulation\|temperatur instabilitet]]		*[[sv:låggradig feber\|låggradig feber]], [[Temperature dysregulation\|temperatur instabilitet]]
	*[[muscle\|muskel]] [[Muscle weakness\|svag]]- och [[Muscle fatigability\|trötthet]]		*[[muscle\|muskel]] [[Muscle weakness\|svag]]- och [[Muscle fatigability\|trötthet]]
	*[[myalgia\|myalgi (muskelsmärta)]]		*[[myalgia\|myalgi (muskelsmärta)]]

Svenska:Låggradig feber

BeardedBaldy — Fri, 13 Nov 2026 23:32:29 GMT

Translation to swedish.

New page

En '''låggradig feber''' (LGF) är när en persons kroppstemperatur är en aning högre än den normala intervallen, men inte hög nog för att kvalificera som feber. En låggradig feber definieras vanligtvis som en kroppstemperatur mellan 37.5°C (99.5°F) och 38.3°C (100.9°F).<ref>{{Cite journal | last = Affronti|first = M. | authorlink = Mario Affronti | last2 = Mansueto | first2 = P. | authorlink2 = Pasquale Mansueto | last3 = Soresi | first3 = M. | authorlink3 = Maurizio Soresi | last4 = Abbene | first4 = A.M. | authorlink4 = | last5 = Affronti | first5 = A. | authorlink5 = Andrea Affronti | last6 = Valenti | first6 = M. | authorlink6 = | last7 = Giannitrapani | first7 = L. | authorlink7 = Lydia Giannitrapani | last8 = Montalto | first8 = G. | authorlink8 = Giuseppe Montalto | date = Feb 2010 | title = Low-grade fever: how to distinguish organic from non-organic forms|url=http://doi.wiley.com/10.1111/j.1742-1241.2009.02256.x|journal=International Journal of Clinical Practice|language=en|volume=64|issue=3 | pages = 316–321|doi=10.1111/j.1742-1241.2009.02256.x|quote=|via=}}</ref> En oral temperatur på minst 38.3 grader klassificeras vanligtvis som feber av okänd ursprung, som i sig själv exkluderar ME/CFS.<ref>{{Cite journal|title=Fever of unexplained origin: report on 100 cases|date=Feb 1961 |url=https://pubmed.ncbi.nlm.nih.gov/13734791/|journal=Medicine|volume=40| last = Petersdorf | first = Robert | authorlink = Robert Petersdorf | last2 = Beeson | first2 = Paul | authorlink2 = Paul Beeson | language=en|doi=10.1097/00005792-196102000-00001|pmid=13734791|issn=0025-7974}}</ref>

==Presentation==

==Förekomst==
*2001, I en Belgisk studie rapporterade 45.7% av patienter som mötte [[Fukuda criteria|Fukudakriterierna]] och 56.5% av patienter som mötte [[Holmes criteria|Holmeskriterierna]] låggradig feber, i en grupp av 2073 [[chronic fatigue syndrome|CFS]]-patienter.<ref>{{Cite journal|last = De Becker | first = Pascale | authorlink = Pascale De Becker | last2 = McGregor | first2 = Neil | authorlink2 = Neil McGregor | last3 = De Meirleir | first3 = Kenny | authorlink3 = Kenny De Meirleir | date = December 2001 | title = A definition‐based analysis of symptoms in a large cohort of patients with chronic fatigue syndrome|url=https://onlinelibrary.wiley.com/doi/full/10.1046/j.1365-2796.2001.00890.x?sid=nlm%3Apubmed|journal=Journal of Internal Medicine|volume=250|issue=3|pages=234–240|doi=10.1046/j.1365-2796.2001.00890.x|quote=|via=}}</ref>

==Symptomigenkänning==
*I [[Holmes criteria|Holmeskriterierna]], är '''mild feber''' (oral temperatur mellan 37.5°C eller 99.5°F och 38.6°C eller 101.5°F, om mätt av patienten) ett alternativt kriterium för diagnos, under sektionen '''Minor Symptom Criteria''' (Mindre Symptomkriterier). Det förekommer också som ett alternativt kriterium under sektionen '''Minor Physical Criteria'''(Mindre Fysiska Kriterier) som '''låggradig feber''' (oral temperatur mellan 37.6°C eller 99.7°F och 38.6°C eller 101.5°F, eller rektal temperatur mellan 37.8°C eller 100°F och 38.8°C eller 102°F) som har dokumenterats av en läkare vid minst två tillfällen med minst en månads mellanrum.<ref>[http://www.cfids-me.org/holmes1988.html The 1988 Holmes Definition for CFS]</ref>

*Återkommande feberkänslor ses som neuroendokrina symptom på ME/CFS i [[Canadian Consensus Criteria|Kanadakriterierna]].

==Nämnvärda studier==

==Möjliga orsaker==

==Möjliga behandlingar==

==Se även==

==Vidare läsning==

==Referenser==
{{reflist}}

[[Category:Signs and symptoms]]
[[Category:Endocrine signs and symptoms]]
[[Category:Immune signs and symptoms]]
[[Category:Swedish-language articles]]

Low-grade fever

BeardedBaldy — Fri, 13 Nov 2026 22:58:11 GMT

Removed "classified as an oral temperature that is" from opening paragraph, to be more consistent with what is written in the referenced article.

← Older revision		Revision as of 22:58, November 13, 2026
(3 intermediate revisions by the same user not shown)
Line 1:		Line 1:
	A '''low-grade fever''' (LGF) is when a person's body temperature is slightly higher than normal range but not high enough to qualify as a fever. A low-grade fever is often ~~classified as an oral temperature that is~~ defined as a body temperature between 99.5°F (37.5°C) and 100.9°F (38.3°C).<ref>{{Cite journal \| last = Affronti\|first = M. \| authorlink = \| last2 = Mansueto \| first2 = P. \| authorlink2 = \| last3 = Soresi \| first3 = M. \| authorlink3 = \| last4 = Abbene \| first4 = A.M. \| authorlink4 = \| last5 = Affronti \| first5 = A. \| authorlink5 = \| last6 = Valenti \| first6 = M. \| authorlink6 = \| last7 = Giannitrapani \| first7 = L. \| last8 = Montalto \| first8 = G. \| date = Feb 2010 \| title = Low-grade fever: how to distinguish organic from non-organic forms\|url=http://doi.wiley.com/10.1111/j.1742-1241.2009.02256.x\|journal=International Journal of Clinical Practice\|language=en\|volume=64\|issue=3 \| pages = 316–321\|doi=10.1111/j.1742-1241.2009.02256.x\|quote=\|via=}}</ref> An oral temperature of 38.3 or above is usually classified as Fever of Unknown Origin, which by itself excludes ME/CFS.<ref>{{Cite journal\|title=Fever of unexplained origin: report on 100 cases\|date=Feb 1961 \|url=https://pubmed.ncbi.nlm.nih.gov/13734791/\|journal=Medicine\|volume=40\|last=Rg\|first=Petersdorf\|last2=Pb\|first2=Beeson\|language=en\|doi=10.1097/00005792-196102000-00001\|pmid=13734791\|issn=0025-7974}}</ref>		{{Language links
			\|page_sv=Låggradig feber
			}}
			A '''low-grade fever''' (LGF) is when a person's body temperature is slightly higher than normal range but not high enough to qualify as a fever. A low-grade fever is often defined as a body temperature between 99.5°F (37.5°C) and 100.9°F (38.3°C).<ref>{{Cite journal \| last = Affronti\|first = M. \| authorlink = Mario Affronti \| last2 = Mansueto \| first2 = P. \| authorlink2 = Pasquale Mansueto \| last3 = Soresi \| first3 = M. \| authorlink3 = Maurizio Soresi \| last4 = Abbene \| first4 = A.M. \| authorlink4 = \| last5 = Affronti \| first5 = A. \| authorlink5 = Andrea Affronti \| last6 = Valenti \| first6 = M. \| authorlink6 = \| last7 = Giannitrapani \| first7 = L. \| authorlink7 = Lydia Giannitrapani \| last8 = Montalto \| first8 = G. \| authorlink8 = Giuseppe Montalto \| date = Feb 2010 \| title = Low-grade fever: how to distinguish organic from non-organic forms\|url=http://doi.wiley.com/10.1111/j.1742-1241.2009.02256.x\|journal=International Journal of Clinical Practice\|language=en\|volume=64\|issue=3 \| pages = 316–321\|doi=10.1111/j.1742-1241.2009.02256.x\|quote=\|via=}}</ref> An oral temperature of 38.3 or above is usually classified as Fever of Unknown Origin, which by itself excludes ME/CFS.<ref>{{Cite journal\|title=Fever of unexplained origin: report on 100 cases\|date=Feb 1961 \|url=https://pubmed.ncbi.nlm.nih.gov/13734791/\|journal=Medicine\|volume=40\| last = Petersdorf \| first = Robert \| authorlink = Robert Petersdorf \| last2 = Beeson \| first2 = Paul \| authorlink2 = Paul Beeson \| language=en\|doi=10.1097/00005792-196102000-00001\|pmid=13734791\|issn=0025-7974}}</ref>

	==Presentation==		==Presentation==
Line 27:		Line 30:
	[[Category:Endocrine signs and symptoms]]		[[Category:Endocrine signs and symptoms]]
	[[Category:Immune signs and symptoms]]		[[Category:Immune signs and symptoms]]
			[[Category:Multilingual pages]]

Canadian Consensus Criteria

BeardedBaldy — Fri, 13 Nov 2026 22:26:38 GMT

Grammar corrections.

← Older revision		Revision as of 22:26, November 13, 2026
Line 1:		Line 1:
	[[File:ME CFS symptoms CCC.png\|frameless\|upright = 0.75\|right\|Simplified Canadian Consensus Criteria for ME/CFS.]]		[[File:ME CFS symptoms CCC.png\|frameless\|upright = 0.75\|right\|Simplified Canadian Consensus Criteria for ME/CFS.]]
	The [[Canadian Consensus Criteria\|Canadian consensus criteria]] (CCC) or the '''Canadian working definition''' are a proposed clinical criteria for [[ME/CFS]], published in 2003, and frequently used as a case definition in research.<ref name="Carruthers, 2003">{{Citation \| last1 = Carruthers \| first1 = Bruce M. \| author-link1 = Bruce Carruthers \| last2 = Jain \| first2 = Anil Kumar \| author-link2 = Anil Kumar Jain \| last3 = De Meirleir \| first3 = Kenny L. \| author-link3 = Kenny De Meirleir \| last4 = Peterson \| first4 = Daniel L. \| author-link4 = Daniel Peterson \| last5 = Klimas \| first5 = Nancy G. \| author-link5 = Nancy Klimas \| last6 = Lerner \| first6 = A. Martin \| author-link6 = Martin Lerner \| last7 = Bested \| first7 = Alison C. \| author-link7 = Alison Bested \| last8 = Flor-Henry \| first8 = Pierre \| author-link8 = Pierre Flor-Henry \| last9 = Joshi \| first9 = Pradip \| author-link9 = Pradip Joshi \| last10 = Powles \| first10 = AC Peter \| author-link10 = A C Peter Powles \| last11 = Sherkey \| first11 = Jeffrey A. \| author-link11 = Jeffrey Sherkey \| last12 = van de Sande \| first12 = Marjorie I. \| author-link12 = Marjorie van de Sande \| title = Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols \| journal = Journal of Chronic Fatigue Syndrome \| volume = 11 \| issue = 2 \| pages = 7-115 \| date = 2003 \| pmid = \| doi = 10.1300/J092v11n01_02 \| url = http://www.meresearch.org.uk/wp-content/uploads/2012/11/2003-Carruthers-Canadian-Definition-JCFS.pdf }}</ref> The Canadian definition is a strictest diagnostic criteria, selecting a smaller group of patients than the [[Fukuda criteria]] and a more severely impaired population.<ref>http://www.meaction.net/2015/12/10/norwegian-researchers-ask-what-exactly-is-m-e/</ref> Adults are diagnosed after a minimum of six months of illness and children after a minimum of three months.		The [[Canadian Consensus Criteria\|Canadian consensus criteria]] (CCC) or the '''Canadian working definition''' are a proposed clinical criteria for [[ME/CFS]], published in 2003, and frequently used as a case definition in research.<ref name="Carruthers, 2003">{{Citation \| last1 = Carruthers \| first1 = Bruce M. \| author-link1 = Bruce Carruthers \| last2 = Jain \| first2 = Anil Kumar \| author-link2 = Anil Kumar Jain \| last3 = De Meirleir \| first3 = Kenny L. \| author-link3 = Kenny De Meirleir \| last4 = Peterson \| first4 = Daniel L. \| author-link4 = Daniel Peterson \| last5 = Klimas \| first5 = Nancy G. \| author-link5 = Nancy Klimas \| last6 = Lerner \| first6 = A. Martin \| author-link6 = Martin Lerner \| last7 = Bested \| first7 = Alison C. \| author-link7 = Alison Bested \| last8 = Flor-Henry \| first8 = Pierre \| author-link8 = Pierre Flor-Henry \| last9 = Joshi \| first9 = Pradip \| author-link9 = Pradip Joshi \| last10 = Powles \| first10 = AC Peter \| author-link10 = A C Peter Powles \| last11 = Sherkey \| first11 = Jeffrey A. \| author-link11 = Jeffrey Sherkey \| last12 = van de Sande \| first12 = Marjorie I. \| author-link12 = Marjorie van de Sande \| title = Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols \| journal = Journal of Chronic Fatigue Syndrome \| volume = 11 \| issue = 2 \| pages = 7-115 \| date = 2003 \| pmid = \| doi = 10.1300/J092v11n01_02 \| url = http://www.meresearch.org.uk/wp-content/uploads/2012/11/2003-Carruthers-Canadian-Definition-JCFS.pdf }}</ref> The Canadian definition is the strictest diagnostic criteria, selecting a smaller group of patients than the [[Fukuda criteria]] and a more severely impaired population.<ref>http://www.meaction.net/2015/12/10/norwegian-researchers-ask-what-exactly-is-m-e/</ref> Adults are diagnosed after a minimum of six months of illness and children after a minimum of three months.

	==Definition==		==Definition==
Line 52:		Line 52:
	* [[thermostatic instability\|Loss of thermostatic stability]] ([[subnormal body temperature]] and marked [[diurnal fluctuation]])		* [[thermostatic instability\|Loss of thermostatic stability]] ([[subnormal body temperature]] and marked [[diurnal fluctuation]])
	* [[Sweating episodes]], recurrent feelings of [[low-grade fever\|feverishness]]		* [[Sweating episodes]], recurrent feelings of [[low-grade fever\|feverishness]]
	* [[cold hands and feet\|cold extremities]] (cold ~~hand~~ and feet)		* [[cold hands and feet\|cold extremities]] (cold hands and feet)
	* [[temperature sensitivity\|Intolerance of extremes of heat and cold]]		* [[temperature sensitivity\|Intolerance of extremes of heat and cold]]
	* Marked [[weight change]] ([[Anorexia (appetite loss)\|anorexia]] or [[abnormal appetite]])		* Marked [[weight change]] ([[Anorexia (appetite loss)\|anorexia]] or [[abnormal appetite]])

Svenska:Halsont

BeardedBaldy — Fri, 13 Nov 2026 22:18:12 GMT

Translation to swedish.

New page

Kroniskt '''halsont''' är ett vanligt symptom som rapporterats i [[sv:ME/CFS|myalgisk encefalomyelit/kroniskt trötthetssyndrom]] (ME/CFS). Det är en ett av en rad influensaliknande symptom som är väldigt vanliga för ME/CFS-patienter.<ref name="Nisenbaum, 2004"/>

==Presentation==
Halsont är speciellt vanligt i början av sjukdomen, då influensaliknande symptom ofta uppkommer. Halsont förekommer oftast på morgonen vid uppvaknandet, eller under [[post-exertional malaise|ansträngningsutlöst försämring]] (PEM). Vissa patienter ser halsont som ett varningstecken som tyder på att de ska minska sin aktivitet.

En bakterie- eller virusinfektion hittas sällan.<ref>Verrillo - Sore throat</ref>

==Förekomst==
*1995, [[sv:Katrina Berne|Katrina Berne]], PhD, rapporterar en förekomst av 50-90% för kroniskt halsont i [[sv:ME/CFS|ME/CFS]].<ref>{{Cite book | last = Berne | first = Katrina | authorlink = Katrina Berne | date = Dec 1, 1995 | title = Running on Empty: The Complete Guide to Chronic Fatigue Syndrome (CFIDS)|edition= 2nd |url= https://www.amazon.co.uk/Running-Empty-Complete-Chronic-Syndrome/dp/0897931912/ |publisher= Hunter House | page = 58 |isbn= 978-0897931915}}</ref>
*2001, I en Belgisk studie rapporterade 74.1% av patienter som mötte [[Fukuda criteria|Fukudakriterierna]] och 84.1% av patienter som mötte [[Holmes criteria|Holmeskriterierna]] att de hade halsont, i en grupp av 2073 [[sv:Kroniskt trötthetssyndrom|CFS]]-patienter.<ref>{{Cite journal | last = De Becker | first=Pascale | authorlink = Pascale De Becker | last2 = McGregor | first2 = Neil | authorlink2 = Neil McGregor | last3 = De Meirleir | first3=Kenny | author-link3 = Kenny De Meirleir | date = December 2001 | title = A definition‐based analysis of symptoms in a large cohort of patients with chronic fatigue syndrome|url=https://onlinelibrary.wiley.com/doi/full/10.1046/j.1365-2796.2001.00890.x?sid=nlm%3Apubmed|journal=Journal of Internal Medicine|volume=250|issue=3|pages=234–240|doi=10.1046/j.1365-2796.2001.00890.x|quote=|via=}}</ref>

==Symptomigenkänning==
*Finns med i [[Fukuda criteria|Fukudakriterierna]], [[Canadian Consensus Criteria|Kanadakriterierna]], [[International Consensus Criteria|Internationella konsensuskriterierna]].
*I [[Canadian Consensus Criteria|Kanadakriterierna]] är kroniskt halsont ett alternativt kriterium för diagnos under sektionen ''Immune Manifestations'' (Immunuttryck).<ref>[http://sacfs.asn.au/download/consensus_overview_me_cfs.pdf ''A Clinical Case Definition and Guidelines for Medical Practitioners: An Overview of the Canadian Consensus Document''] Pg 8. 2005.</ref>
*I [[Fukuda criteria|Fukudakriterierna]] kan symptomen av halsont användas som hjälp vid diagnostisering.<ref>[http://www.cfids-me.org/cdcdefine.html The CDC (Fukuda 1994) Definition for Chronic Fatigue Syndrome]</ref>
*I [[Holmes criteria|Holmeskriterierna]] är halsont ett alternativt kriterium för diagnos under sektionen ''Minor Symptom Criteria'' (Mindre Symptomkriterier).<ref>[http://www.cfids-me.org/holmes1988.html The 1988 Holmes Definition for CFS]</ref>

==Nämnvärda studier==

==Möjliga orsaker==

==Möjliga behandlingar==
*Örtteer
*Varm citron och honung
*Halsspray och halstablett
*[[Zinc|Zink]]

==Se även==

==Vidare läsning==

==Referenser==
<references>
<ref name="Nisenbaum, 2004">
{{Citation | last1 = Nisenbaum | first1 = R | authorlink1 = Rosane Nisenbaum| last2 = Reyes | first2 = M | authorlink2 = Michele Reyes | last3 = Unger | first3 = ER | authorlink3 = Elizabeth Unger | last4 = Reeves | first4 = W | authorlink4 = William Reeves | title = Factor analysis of symptoms among subjects with unexplained chronic fatigue: what can we learn about chronic fatigue syndrome? | url = https://www.sciencedirect.com/science/article/abs/pii/S0022399903000394?via%3Dihub | journal = J Psychosom Res. | volume = 56 | issue = 2 | page = 171-8 | date = Feb 2004 | pmid = 15016574
| doi = 10.1016/S0022-3999(03)00039-4 }}</ref>
</references>

[[Category:Signs and symptoms]]
[[Category:Pain signs and symptoms]]
[[Category:Oral signs and symptoms]]
[[Category:Immune signs and symptoms]]
[[Category:Digestive signs and symptoms]]
[[Category:Swedish-language articles]]

Sore throat

BeardedBaldy — Fri, 13 Nov 2026 21:41:17 GMT

← Older revision		Revision as of 21:41, November 13, 2026
(2 intermediate revisions by the same user not shown)
Line 1:		Line 1:
			{{Language links
			\|page_sv=Halsont
			}}
	A chronic '''sore throat''' is a commonly reported symptom in [[ME/CFS\|myalgic encephalomyelitis/chronic fatigue syndrome]] ([[ME/CFS]]). It forms part of a range of flu-like symptoms that are very common in ME/CFS patients.<ref name="Nisenbaum, 2004"/>		A chronic '''sore throat''' is a commonly reported symptom in [[ME/CFS\|myalgic encephalomyelitis/chronic fatigue syndrome]] ([[ME/CFS]]). It forms part of a range of flu-like symptoms that are very common in ME/CFS patients.<ref name="Nisenbaum, 2004"/>

Line 34:		Line 37:
	<references>		<references>
	<ref name="Nisenbaum, 2004">		<ref name="Nisenbaum, 2004">
	{{Citation \| last1 = Nisenbaum \| first1 = R \| authorlink1 = Rosane Nisenbaum\| last2 = Reyes \| first2 = M \| authorlink2 = \| last3 = Unger \| first3 = ER \| authorlink3 = Elizabeth Unger \| last4 = Reeves \| first4 = W \| authorlink4 = William Reeves \| title = Factor analysis of symptoms among subjects with unexplained chronic fatigue: what can we learn about chronic fatigue syndrome? \| journal = J Psychosom Res. \| volume = 56 \| issue = 2 \| page = 171-8 \| date = Feb 2004 \| pmid = 15016574		{{Citation \| last1 = Nisenbaum \| first1 = R \| authorlink1 = Rosane Nisenbaum\| last2 = Reyes \| first2 = M \| authorlink2 = Michele Reyes \| last3 = Unger \| first3 = ER \| authorlink3 = Elizabeth Unger \| last4 = Reeves \| first4 = W \| authorlink4 = William Reeves \| title = Factor analysis of symptoms among subjects with unexplained chronic fatigue: what can we learn about chronic fatigue syndrome? \| url = https://www.sciencedirect.com/science/article/abs/pii/S0022399903000394?via%3Dihub \| journal = J Psychosom Res. \| volume = 56 \| issue = 2 \| page = 171-8 \| date = Feb 2004 \| pmid = 15016574
	\| doi = 10.1016/S0022-3999(03)00039-4 }}</ref>		\| doi = 10.1016/S0022-3999(03)00039-4 }}</ref>
	</references>		</references>
Line 43:		Line 46:
	[[Category:Immune signs and symptoms]]		[[Category:Immune signs and symptoms]]
	[[Category:Digestive signs and symptoms]]		[[Category:Digestive signs and symptoms]]
			[[Category:Multilingual pages]]

Rare and uncommon symptoms

BeardedBaldy — Fri, 13 Nov 2026 21:09:55 GMT

Added authorlinks in references.

← Older revision		Revision as of 21:09, November 13, 2026
(One intermediate revision by the same user not shown)
Line 1:		Line 1:
	Rare and uncommon symptoms of [[myalgic encephalomyelitis]] (ME) are those not listed the diagnostic criteria, and are more likely to occur or more likely to be problematic in people with [[Severe and very severe ME\|severe or very severe ME]].<ref name="Becker2001">{{Cite journal \| last = De Becker \| first=P. \| last2 = McGregor \| first2 = N. \| last3 = De Meirleir \| first3 = K. \| date = 2001-09-15\| title = A definition-based analysis of symptoms in a large cohort of patients with chronic fatigue syndrome\|url=https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2796.2001.00890.x\|journal=Journal of Internal Medicine\|volume=250\|issue=3\|pages=234–240\|doi=10.1046/j.1365-2796.2001.00890.x\|issn=0954-6820\|pmc=\|pmid=\|quote= \| author-link = Pascale De Becker \| authorlink2 = Neil McGregor\|access-date= \| authorlink3 = Kenny De Meirleir \| authorlink4 = \| authorlink5 = \|via=}}</ref><ref name="Jason2014">{{Cite journal \| last= Jason \| first = Leonard A. \| last2 = Sunnquist \| first2 = Madison \| last3 = Brown \| first3 = Abigail \| last4 = Evans \| first4 = Meredyth \| last5 = Vernon \| first5 = Suzanne D. \| last6 = Furst \| first6 = Jacob \| last7 = Simonis \| first7 = Valerie \| date = 2014-01-01\| title = Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis\|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912876/\|journal=Fatigue: biomedicine, health & behavior\|volume=2\|issue=1 \| pages = 40–56\|doi=10.1080/21641846.2013.862993\|issn=2164-1846\|pmc=3912876\|pmid=24511456\|quote= \| author-link = Leonard Jason \| author-link2 = Madison Sunnquist\|access-date= \| authorlink3 = Abigail Brown \| author-link4 = Meredyth Evans \| author-link5 = Suzanne Vernon\|via=}}</ref>		Rare and uncommon symptoms of [[myalgic encephalomyelitis]] (ME) are those not listed the diagnostic criteria, and are more likely to occur or more likely to be problematic in people with [[Severe and very severe ME\|severe or very severe ME]].<ref name="Becker2001">{{Cite journal \| last = De Becker \| first=P. \| last2 = McGregor \| first2 = N. \| last3 = De Meirleir \| first3 = K. \| date = 2001-09-15\| title = A definition-based analysis of symptoms in a large cohort of patients with chronic fatigue syndrome\|url=https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2796.2001.00890.x\|journal=Journal of Internal Medicine\|volume=250\|issue=3\|pages=234–240\|doi=10.1046/j.1365-2796.2001.00890.x\|issn=0954-6820\|pmc=\|pmid=\|quote= \| author-link = Pascale De Becker \| authorlink2 = Neil McGregor\|access-date= \| authorlink3 = Kenny De Meirleir \| authorlink4 = \| authorlink5 = \|via=}}</ref><ref name="Jason2014">{{Cite journal \| last= Jason \| first = Leonard A. \| last2 = Sunnquist \| first2 = Madison \| last3 = Brown \| first3 = Abigail \| last4 = Evans \| first4 = Meredyth \| last5 = Vernon \| first5 = Suzanne D. \| last6 = Furst \| first6 = Jacob \| authorlink6 = Jacob Furst \| last7 = Simonis \| first7 = Valerie \| authorlink7 = Valerie Simonis \| date = 2014-01-01\| title = Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis\|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912876/\|journal=Fatigue: biomedicine, health & behavior\|volume=2\|issue=1 \| pages = 40–56\|doi=10.1080/21641846.2013.862993\|issn=2164-1846\|pmc=3912876\|pmid=24511456\|quote= \| author-link = Leonard Jason \| author-link2 = Madison Sunnquist\|access-date= \| authorlink3 = Abigail Brown \| author-link4 = Meredyth Evans \| author-link5 = Suzanne Vernon\|via=}}</ref>

	Rare symptoms that can be particularly problematic include:		Rare symptoms that can be particularly problematic include:
Line 7:		Line 7:
	* [[cardiovascular]] symptoms like [[heart palpitation]]s		* [[cardiovascular]] symptoms like [[heart palpitation]]s
	* nocturnal [[diarrhea]], bladder and bowel control problems<ref name=":5" />		* nocturnal [[diarrhea]], bladder and bowel control problems<ref name=":5" />
	* [[blackouts]] or loss of consciousness<ref name="HFME">{{Cite web\|url=https://www.hfme.org/themesymptomlist.htm\| title = The comprehensive M.E. symptom list \| last = Bassett \| first=Jodi \| date = 2012 \| website = The Hummingbirds' Foundation\|archive-url=https://web.archive.org/web/20180330194015/http://www.hfme.org/themesymptomlist.htm\|archive-date=2018-03-30\|url-status=\|access-date=2018-10-07\|authorlink=Jodi Bassett}}</ref><ref>{{Cite news \| url=https://25megroup.org/me/symptoms\| title = Symptoms - 25% M.E. Group\|work=25% M.E. Group\|access-date=2018-10-07\|language=en-US}}</ref><ref name="Becker2001" /><ref name="CCC">{{Cite journal \| last = Carruthers \| first = Bruce M. \| last2 = Jain \| first2 = Anil Kumar \| last3 = De Meirleir \| first3 = Kenny L. \| last4 = Peterson \| first4 = Daniel L. \| last5 = Klimas \| first5 = Nancy G. \| last6 = Lerner \| first6 = A. Martin \| last7 = Bested \| first7 = Alison C. \| last8 = Flor-Henry \| first8 = Pierre \| last9 = Joshi \| first9 = Pradip \| date = May 2002\| title = Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Clinical Working Case Definition, Diagnostic and Treatment Protocols\|url=http://www.investinme.org/Documents/PDFdocuments/CanadianDefinitionME-CFS.pdf#page=10\|journal=Journal of Chronic Fatigue Syndrome\|language=en\|volume=11\|issue=1 \| pages = 7–115\|doi=10.1300/j092v11n01_02\|issn=1057-3321\|via=\|pmc=\|pmid=\|quote= \| author-link = Bruce Carruthers \| authorlink2 = Anil Kumar Jain\|access-date= \| authorlink3 = Kenny De Meirleir \| authorlink4 = Daniel Peterson \| author-link5 = Nancy Klimas \| authorlink6 = A Martin Lerner \| authorlink7 = Alison Bested \| authorlink8 = Pierre Flor-Henry \| authorlink9 = Pradip Joshi}}</ref><ref>{{Cite journal \| last = Amano \| first = Keiko \| last2 = Yanagihori \| first2 = Ryoko \| last3 = Tei \| first3 = Chuwa \| date = 2015-05-13\| title = Waon Therapy is Effective as the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome\|url=https://www.jstage.jst.go.jp/article/onki/78/3/78_285/_pdf\|journal=The Journal of The Japanese Society of Balneology, Climatology and Physical Medicine\|language=en\|volume=78\|issue=3\|pages=\|doi=10.11390/onki.78.285\|issn=0029-0343\|via=}}</ref><ref name=":3">{{Cite journal \| last = Crowhurst \| first=Greg \| date = 28 February 2005\| title = Supporting people with severe myalgic encephalomyelitis\|url=http://me-foreningen.dk/wp-content/uploads/2016/10/Crowhurst-Severely-affected-i-Nursing-Standard.pdf\|journal=Nursing Standard (Royal College of Nursing (Great Britain): 1987)\|volume=19\|issue=21\|pages=38–43\|doi=10.7748/ns2005.02.19.21.38.c3796\|issn=0029-6570\|pmid=15727017\|via=\|pmc=\|quote= \| author-link = Greg Crowhurst}}</ref>		* [[blackouts]] or loss of consciousness<ref name="HFME">{{Cite web\|url=https://www.hfme.org/themesymptomlist.htm\| title = The comprehensive M.E. symptom list \| last = Bassett \| first=Jodi \| date = 2012 \| website = The Hummingbirds' Foundation\|archive-url=https://web.archive.org/web/20180330194015/http://www.hfme.org/themesymptomlist.htm\|archive-date=2018-03-30\|url-status=\|access-date=2018-10-07\|authorlink=Jodi Bassett}}</ref><ref>{{Cite news \| url=https://25megroup.org/me/symptoms\| title = Symptoms - 25% M.E. Group\|work=25% M.E. Group\|access-date=2018-10-07\|language=en-US}}</ref><ref name="Becker2001" /><ref name="CCC">{{Cite journal \| last = Carruthers \| first = Bruce M. \| last2 = Jain \| first2 = Anil Kumar \| last3 = De Meirleir \| first3 = Kenny L. \| last4 = Peterson \| first4 = Daniel L. \| last5 = Klimas \| first5 = Nancy G. \| last6 = Lerner \| first6 = A. Martin \| last7 = Bested \| first7 = Alison C. \| last8 = Flor-Henry \| first8 = Pierre \| last9 = Joshi \| first9 = Pradip \| date = May 2002\| title = Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Clinical Working Case Definition, Diagnostic and Treatment Protocols\|url=http://www.investinme.org/Documents/PDFdocuments/CanadianDefinitionME-CFS.pdf#page=10\|journal=Journal of Chronic Fatigue Syndrome\|language=en\|volume=11\|issue=1 \| pages = 7–115\|doi=10.1300/j092v11n01_02\|issn=1057-3321\|via=\|pmc=\|pmid=\|quote= \| author-link = Bruce Carruthers \| authorlink2 = Anil Kumar Jain\|access-date= \| authorlink3 = Kenny De Meirleir \| authorlink4 = Daniel Peterson \| author-link5 = Nancy Klimas \| authorlink6 = A Martin Lerner \| authorlink7 = Alison Bested \| authorlink8 = Pierre Flor-Henry \| authorlink9 = Pradip Joshi}}</ref><ref>{{Cite journal \| last = Amano \| first = Keiko \| authorlink = Keiko Amano \| last2 = Yanagihori \| first2 = Ryoko \| authorlink2 = Ryoko Yanagihori \| last3 = Tei \| first3 = Chuwa \| authorlink3 = Chuwa Tei \| date = 2015-05-13\| title = Waon Therapy is Effective as the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome\|url=https://www.jstage.jst.go.jp/article/onki/78/3/78_285/_pdf\|journal=The Journal of The Japanese Society of Balneology, Climatology and Physical Medicine\|language=en\|volume=78\|issue=3\|pages=\|doi=10.11390/onki.78.285\|issn=0029-0343\|via=}}</ref><ref name=":3">{{Cite journal \| last = Crowhurst \| first=Greg \| date = 28 February 2005\| title = Supporting people with severe myalgic encephalomyelitis\|url=http://me-foreningen.dk/wp-content/uploads/2016/10/Crowhurst-Severely-affected-i-Nursing-Standard.pdf\|journal=Nursing Standard (Royal College of Nursing (Great Britain): 1987)\|volume=19\|issue=21\|pages=38–43\|doi=10.7748/ns2005.02.19.21.38.c3796\|issn=0029-6570\|pmid=15727017\|via=\|pmc=\|quote= \| author-link = Greg Crowhurst}}</ref>

	==Sensory problems==		==Sensory problems==
Line 19:		Line 19:

	=== Chewing and swallowing problems ===		=== Chewing and swallowing problems ===
	Chewing and swallowing problems are sometimes caused by paralysis, especially facial paralysis. Some patients are too weak to chew, eat or digest food normally and need a feeding tube.<ref>{{Cite journal \| last = Hanson \| first = Maureen R. \| last2 = Giloteaux \| first2 = Ludovic \| date = 2017 \| title=The gut microbiome in Myalgic Encephalomyelitis\|url=http://www.biochemist.org/bio/03902/0010/039020010.pdf\|journal=Biochemist\|volume=39\|issue=2\|pages=10-13\|via=\| doi = \| pmc = \| pmid = \| quote = \| authorlink = Maureen Hanson}}</ref><ref name="HFME" /> Problems with fine motor control of the hands can also affect eating.<ref name=":3" /><ref>{{Cite web\|url=https://www.mesupport.co.uk/index.php?page=the-symptoms-of-m-e\| title = The Symptoms of Myalgic Encephalomyelitis - M.E. Support \| last = Sargent \| first = Louise \| date = \|website=mesupport.co.uk\|language=en\|archive-url=\|archive-date=\|url-status=\|access-date=2018-10-16}}</ref>		Chewing and swallowing problems are sometimes caused by paralysis, especially facial paralysis. Some patients are too weak to chew, eat or digest food normally and need a feeding tube.<ref>{{Cite journal \| last = Hanson \| first = Maureen R. \| last2 = Giloteaux \| first2 = Ludovic \| authorlink2 = Ludovic Giloteaux \| date = 2017 \| title=The gut microbiome in Myalgic Encephalomyelitis\|url=http://www.biochemist.org/bio/03902/0010/039020010.pdf\|journal=Biochemist\|volume=39\|issue=2\|pages=10-13\|via=\| doi = \| pmc = \| pmid = \| quote = \| authorlink = Maureen Hanson}}</ref><ref name="HFME" /> Problems with fine motor control of the hands can also affect eating.<ref name=":3" /><ref>{{Cite web\|url=https://www.mesupport.co.uk/index.php?page=the-symptoms-of-m-e\| title = The Symptoms of Myalgic Encephalomyelitis - M.E. Support \| last = Sargent \| first = Louise \| authorlink = Louise Sargent \| date = \|website=mesupport.co.uk\|language=en\|archive-url=\|archive-date=\|url-status=\|access-date=2018-10-16}}</ref>

	=== Nocturnal diarrhea ===		=== Nocturnal diarrhea ===
	Nightime diarrhea and delayed emptying of the upper gastricintestinal tract were found in some CFS patients, although vomiting was much rarer in the same study.<ref name=":5">{{Cite journal \| last = Burnet \| first = Richard B \| last2 = Chatterton \| first2 = Barry E \| date = December 2004\| title = Gastric emptying is slow in chronic fatigue syndrome\|url=https://bmcgastroenterol.biomedcentral.com/articles/10.1186/1471-230X-4-32\|journal=BMC Gastroenterology\|language=en\|volume=4\|issue=1\|pages=\|doi=10.1186/1471-230x-4-32\|issn=1471-230X\|pmc=544348\|pmid=15619332\|via=}}</ref> Difficulties with bladder or bowel control have also been identified.<ref name=":6" />		Nightime diarrhea and delayed emptying of the upper gastricintestinal tract were found in some CFS patients, although vomiting was much rarer in the same study.<ref name=":5">{{Cite journal \| last = Burnet \| first = Richard B \| authorlink = Richard Burnet \| last2 = Chatterton \| first2 = Barry E \| authorlink2 = Barry Chatterton \| date = December 2004\| title = Gastric emptying is slow in chronic fatigue syndrome\|url=https://bmcgastroenterol.biomedcentral.com/articles/10.1186/1471-230X-4-32\|journal=BMC Gastroenterology\|language=en\|volume=4\|issue=1\|pages=\|doi=10.1186/1471-230x-4-32\|issn=1471-230X\|pmc=544348\|pmid=15619332\|via=}}</ref> Difficulties with bladder or bowel control have also been identified.<ref name=":6" />

	=== Seizure-like symptoms ===		=== Seizure-like symptoms ===
	[[Seizure\|Seizure-like symptoms]] are described as resulting from hypersensitivity to even low levels of a stimulus (to light, noise, chemicals, etc).<ref>{{Cite journal \| last = Chaudhury \| first = Suprakash \| date = 2014-07-01\| title = Cognitive impairments in chronic fatigue syndrome\|url=http://www.mjdrdypu.org/article.asp?issn=0975-2870;year=2014;volume=7;issue=4;spage=422;epage=424;aulast=Chaudhury\|journal=Medical Journal of Dr. D.Y. Patil University\|language=en\|volume=7\|issue=4}}</ref> Seizure-like symptoms are included in the ''[[Nervous system\|Nervous System]]'' symptoms in the Canadian Consensus Criteria (Appendix 4).<ref name="CCC" />{{Rp\|102-103}}		[[Seizure\|Seizure-like symptoms]] are described as resulting from hypersensitivity to even low levels of a stimulus (to light, noise, chemicals, etc).<ref>{{Cite journal \| last = Chaudhury \| first = Suprakash \| authorlink = Suprakash Chaudhury \| date = 2014-07-01\| title = Cognitive impairments in chronic fatigue syndrome\|url=http://www.mjdrdypu.org/article.asp?issn=0975-2870;year=2014;volume=7;issue=4;spage=422;epage=424;aulast=Chaudhury\|journal=Medical Journal of Dr. D.Y. Patil University\|language=en\|volume=7\|issue=4}}</ref> Seizure-like symptoms are included in the ''[[Nervous system\|Nervous System]]'' symptoms in the Canadian Consensus Criteria (Appendix 4).<ref name="CCC" />{{Rp\|102-103}}

	==Prevalence==		==Prevalence==

Svenska:Stress

BeardedBaldy — Fri, 13 Nov 2026 00:08:08 GMT

Relocate lang link.

← Older revision		Revision as of 00:08, November 13, 2026
Line 1:		Line 1:
	{{stub}}		{{stub}}

	'''Stress''' kan vara antingen fysisk eller psykisk, eller både och.<ref name="physiologicalstress" /> Stress defineras som antingen ett tillstånd av emotionell eller [[mental health\|psykologisk påfrestning]] eller spänning orsakad av en situation eller händelse, ''eller'' den fysiska stress(tryck eller spänning) som utövas på ett fysiskt objekt, såsom en kroppsdel, t.ex. ett '''stresstest''' är ett medicinskt test som övervakar det [[~~cardiovascular system~~\|kardiovaskulära systemet]] under ansträngande [[exercise\|träning]].<ref name="oxdict">{{Cite book \| title=New Oxford American Dictionary \| date = 2015 \| publisher =Oxford University Press \| editor-first = Angus \| editor-last = Stevenson\|editor-first2 = Christine A.\|editor-last2=Lindberg}}</ref><ref name="stresstest">{{Cite web\|url=https://www.webmd.com/heart-disease/guide/stress-test \| title = Heart Disease and Stress Tests\|website=WebMD\|language=en\|access-date=2021-03-11}}</ref>		'''Stress''' kan vara antingen fysisk eller psykisk, eller både och.<ref name="physiologicalstress" /> Stress defineras som antingen ett tillstånd av emotionell eller [[mental health\|psykologisk påfrestning]] eller spänning orsakad av en situation eller händelse, ''eller'' den fysiska stress(tryck eller spänning) som utövas på ett fysiskt objekt, såsom en kroppsdel, t.ex. ett '''stresstest''' är ett medicinskt test som övervakar det [[sv:Kardiovaskulära systemet\|kardiovaskulära systemet]] under ansträngande [[exercise\|träning]].<ref name="oxdict">{{Cite book \| title=New Oxford American Dictionary \| date = 2015 \| publisher =Oxford University Press \| editor-first = Angus \| editor-last = Stevenson\|editor-first2 = Christine A.\|editor-last2=Lindberg}}</ref><ref name="stresstest">{{Cite web\|url=https://www.webmd.com/heart-disease/guide/stress-test \| title = Heart Disease and Stress Tests\|website=WebMD\|language=en\|access-date=2021-03-11}}</ref>

	==Bra stress ==		==Bra stress ==

Svenska:Myalgisk encefalomyelit

BeardedBaldy — Fri, 13 Nov 2026 00:07:12 GMT

Relocate lang link.

← Older revision		Revision as of 00:07, November 13, 2026
Line 3:		Line 3:
	[[File:Jenny Spotlia.jpg\|300px\|thumb\|right\|[[Jennie Spotila]] är en amerikansk ME patient som insjuknade den 6e Oktober 1994. Jennie är [[Severe and very severe ME\|handikappad, mestadels hembunden, och använder en rullstol]] men har varit en [[sv:ME/CFS\|ME/CFS]] förespråkare i många år. Hon skriver bloggen [[Occupy M.E.]] Hon tjänade satt i styrelsen för [[Solve ME/CFS Initiative\|CFIDS Association of America]] (Amerikas CFIDS Förbund) och vittnade inför [[Chronic Fatigue Syndrome Advisory Committee\|CFSAC]]]]		[[File:Jenny Spotlia.jpg\|300px\|thumb\|right\|[[Jennie Spotila]] är en amerikansk ME patient som insjuknade den 6e Oktober 1994. Jennie är [[Severe and very severe ME\|handikappad, mestadels hembunden, och använder en rullstol]] men har varit en [[sv:ME/CFS\|ME/CFS]] förespråkare i många år. Hon skriver bloggen [[Occupy M.E.]] Hon tjänade satt i styrelsen för [[Solve ME/CFS Initiative\|CFIDS Association of America]] (Amerikas CFIDS Förbund) och vittnade inför [[Chronic Fatigue Syndrome Advisory Committee\|CFSAC]]]]

	'''Myalgisk encefalomyelit''' (ME) är en kronisk, [[sv:Inflammation\|inflammatorisk]], fysisk och [[sv:Nervsystem\|neurologisk]] och immun-förmedlad sjukdom med symptom som involverar många kroppssystem. Den blir ofta utlöst av en [[sv:Virusinfektion\|virusinfektion]] eller en [[sv:Influensaliknande sjukdom\|influensaliknande sjukdom]].<ref name="ICC2011primer" /><ref name="CDC-causes" /> ME för med sig symptom i [[sv:Centrala nervsystemet\|centrala nervsystemet]] (CNS), [[sv:Autonoma nervsystemet\|autonoma nervsystemet]] (ANS), [[immune system\|immunsystemet]], [[~~cardiovascular system~~\|kardiovaskulära systemet]], [[endocrine system\|endokrina systemet]], [[digestive system\|matsmältningssystemet]], och [[musculoskeletal system\|muskuloskeletala systemet]].<ref name="ICC2011primer" /><ref name="CDC-symptoms" />		'''Myalgisk encefalomyelit''' (ME) är en kronisk, [[sv:Inflammation\|inflammatorisk]], fysisk och [[sv:Nervsystem\|neurologisk]] och immun-förmedlad sjukdom med symptom som involverar många kroppssystem. Den blir ofta utlöst av en [[sv:Virusinfektion\|virusinfektion]] eller en [[sv:Influensaliknande sjukdom\|influensaliknande sjukdom]].<ref name="ICC2011primer" /><ref name="CDC-causes" /> ME för med sig symptom i [[sv:Centrala nervsystemet\|centrala nervsystemet]] (CNS), [[sv:Autonoma nervsystemet\|autonoma nervsystemet]] (ANS), [[immune system\|immunsystemet]], [[sv:Kardiovaskulära systemet\|kardiovaskulära systemet]], [[endocrine system\|endokrina systemet]], [[digestive system\|matsmältningssystemet]], och [[musculoskeletal system\|muskuloskeletala systemet]].<ref name="ICC2011primer" /><ref name="CDC-symptoms" />

	Myalgisk encefalomyelit klassades först som en [[sv:nervsystem\|neurologisk]] sjukdom av [[World Health Organization\|Världshälsoorganisationen]] (WHO) 1969 med publiceringen av [[World Health Organization#icd8\|Världshälsoorganisationens ICD-8]] manual.<ref name="ICD-8">{{Cite book \|url=https://apps.who.int/iris/bitstream/handle/10665/70934/ICD_10_1969_eng_v2a.pdf \| title=Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death Based on the Recommendations of the Eighth Revision Conference \| last = World Health Organization \| first = \| authorlink = World Health Organization\|publisher=WHO\| year = 1969\|isbn=\|editor-link=\|edition=8th\|volume=2\|location=Geneva \| page = 173\|chapter=\|quote=Encephalomyelitis (chronic),<br>(myalgic, benign) 323}}</ref>		Myalgisk encefalomyelit klassades först som en [[sv:nervsystem\|neurologisk]] sjukdom av [[World Health Organization\|Världshälsoorganisationen]] (WHO) 1969 med publiceringen av [[World Health Organization#icd8\|Världshälsoorganisationens ICD-8]] manual.<ref name="ICD-8">{{Cite book \|url=https://apps.who.int/iris/bitstream/handle/10665/70934/ICD_10_1969_eng_v2a.pdf \| title=Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death Based on the Recommendations of the Eighth Revision Conference \| last = World Health Organization \| first = \| authorlink = World Health Organization\|publisher=WHO\| year = 1969\|isbn=\|editor-link=\|edition=8th\|volume=2\|location=Geneva \| page = 173\|chapter=\|quote=Encephalomyelitis (chronic),<br>(myalgic, benign) 323}}</ref>

Svenska:Kardiovaskulära systemet

BeardedBaldy — Thu, 12 Nov 2026 23:47:03 GMT

Corrected spelling error.

← Older revision		Revision as of 23:47, November 12, 2026
Line 10:		Line 10:
	En [[Netherlands\|Nederländsk]] studie 2016 var först med att använda kontrastförstärkt kardiell magnetresonanstomografi (CMR) för att utvärdera hjärtengagemang i kvinnor med CFS. Tolv kvinnor som hade en CDS-diagnos baserad på [[Fukuda criteria\|Fukudakriterierna]] rekryterades från ett specialiserat CFS-center. Trettiosex kontroller som hade matchande ålder och kön inkluderades också. Slutsatserna var att kardiell magnetresonanstomografi visade att patienter med CFS har mindre dimension på den nedre vänstra ventrikeln och lätt nedsatt funktion av den vänstra ventrikeln. Abnormaliteter i rörelsen av hjärtats väggar och närvaron av myokardiell fibros observerades i vissa CFS-patienter.<ref name="Olimulder, 2016" />		En [[Netherlands\|Nederländsk]] studie 2016 var först med att använda kontrastförstärkt kardiell magnetresonanstomografi (CMR) för att utvärdera hjärtengagemang i kvinnor med CFS. Tolv kvinnor som hade en CDS-diagnos baserad på [[Fukuda criteria\|Fukudakriterierna]] rekryterades från ett specialiserat CFS-center. Trettiosex kontroller som hade matchande ålder och kön inkluderades också. Slutsatserna var att kardiell magnetresonanstomografi visade att patienter med CFS har mindre dimension på den nedre vänstra ventrikeln och lätt nedsatt funktion av den vänstra ventrikeln. Abnormaliteter i rörelsen av hjärtats väggar och närvaron av myokardiell fibros observerades i vissa CFS-patienter.<ref name="Olimulder, 2016" />

	Minskad hjärtvolym har associerats med blodvolym, men inte med sjukdomens varaktighet.<ref name=":0">{{Cite journal \| last = Blamire \| first = Andrew M. \| authorlink = Andrew Blamire \| last2 = MacGowan \| first2 = Guy \| authorlink2 = Guy ~~McGowan~~ \| last3 = Maclachlan \| first3 = Laura \| authorlink3 = Laura Maclachlan \| last4 = Hodgson \| first4 = Tim \| authorlink4 = Tim Hodgson \| last5 = Frith \| first5 = James \| authorlink5 = James Frith \| last6 = Petrides \| first6 = George \| authorlink6 = George Petrides \| last7 = Finkelmeyer \| first7 = Andreas \| authorlink7 = Andreas Finkelmeyer \| last8 = Newton \| first8 = Julia L. \| authorlink8 = Julia Newton \| date = 2016-06-01 \| title = Reduced cardiac volumes in chronic fatigue syndrome associate with plasma volume but not length of disease: a cohort study \| url = https://openheart.bmj.com/content/3/1/e000381 \| journal = Open Heart\|language=en \| volume = 3 \| issue = 1\| pages = e000381\|doi=10.1136/openhrt-2015-000381\|issn=2053-3624}}</ref>		Minskad hjärtvolym har associerats med blodvolym, men inte med sjukdomens varaktighet.<ref name=":0">{{Cite journal \| last = Blamire \| first = Andrew M. \| authorlink = Andrew Blamire \| last2 = MacGowan \| first2 = Guy \| authorlink2 = Guy MacGowan \| last3 = Maclachlan \| first3 = Laura \| authorlink3 = Laura Maclachlan \| last4 = Hodgson \| first4 = Tim \| authorlink4 = Tim Hodgson \| last5 = Frith \| first5 = James \| authorlink5 = James Frith \| last6 = Petrides \| first6 = George \| authorlink6 = George Petrides \| last7 = Finkelmeyer \| first7 = Andreas \| authorlink7 = Andreas Finkelmeyer \| last8 = Newton \| first8 = Julia L. \| authorlink8 = Julia Newton \| date = 2016-06-01 \| title = Reduced cardiac volumes in chronic fatigue syndrome associate with plasma volume but not length of disease: a cohort study \| url = https://openheart.bmj.com/content/3/1/e000381 \| journal = Open Heart\|language=en \| volume = 3 \| issue = 1\| pages = e000381\|doi=10.1136/openhrt-2015-000381\|issn=2053-3624}}</ref>

	En studie fann att blodvolym är starkt fysiologiskt relaterat till den högsta syrekonsumptionen i CFS-patienter.<ref name=":1">{{Cite journal \| last = Farquhar \| first = William B. \| authorlink = William Farquhar \| last2 = Hunt \| first2 = Brian E. \| authorlink2 = Brian Hunt \| last3 = Taylor \| first3 = J. Andrew \| authorlink3 = Andrew Taylor \| last4 = Darling \| first4 = Stephen E. \| authorlink4 = Stephen Darling \| last5 = Freeman \| first5 = Roy \| authorlink5 = Roy Freeman \| date = 2002-01-01 \| title = Blood volume and its relation to peak O2consumption and physical activity in patients with chronic fatigue \| url =https://www.physiology.org/doi/full/10.1152/ajpheart.2002.282.1.h66 \| journal = American Journal of Physiology-Heart and Circulatory Physiology \| volume = 282 \| issue = 1\| pages=H66–H71\|doi=10.1152/ajpheart.2002.282.1.H66\|issn=0363-6135}}</ref>		En studie fann att blodvolym är starkt fysiologiskt relaterat till den högsta syrekonsumptionen i CFS-patienter.<ref name=":1">{{Cite journal \| last = Farquhar \| first = William B. \| authorlink = William Farquhar \| last2 = Hunt \| first2 = Brian E. \| authorlink2 = Brian Hunt \| last3 = Taylor \| first3 = J. Andrew \| authorlink3 = Andrew Taylor \| last4 = Darling \| first4 = Stephen E. \| authorlink4 = Stephen Darling \| last5 = Freeman \| first5 = Roy \| authorlink5 = Roy Freeman \| date = 2002-01-01 \| title = Blood volume and its relation to peak O2consumption and physical activity in patients with chronic fatigue \| url =https://www.physiology.org/doi/full/10.1152/ajpheart.2002.282.1.h66 \| journal = American Journal of Physiology-Heart and Circulatory Physiology \| volume = 282 \| issue = 1\| pages=H66–H71\|doi=10.1152/ajpheart.2002.282.1.H66\|issn=0363-6135}}</ref>

Cardiovascular system

BeardedBaldy — Thu, 12 Nov 2026 23:46:10 GMT

Corrected spelling error.

← Older revision		Revision as of 23:46, November 12, 2026
Line 14:		Line 14:
	A 2016 study in the [[Netherlands]] was the first to use contrast-enhanced cardiac magnetic resonance (CMR) imaging in assessing cardiac involvement in women who have CFS. Twelve women were recruited from a specialised CFS centre who had a diagnosis of CFS based on the [[Fukuda criteria]]. Thirty-six age- and gender-matched controls were also included. The conclusions were that in patients with CFS, cardiac magnetic resonance demonstrated lower left ventricle dimensions and a mildly reduced left ventricle function. Heart wall motion abnormalities and the presence of myocardial fibrosis were observed in some CFS patients.<ref name="Olimulder, 2016" />		A 2016 study in the [[Netherlands]] was the first to use contrast-enhanced cardiac magnetic resonance (CMR) imaging in assessing cardiac involvement in women who have CFS. Twelve women were recruited from a specialised CFS centre who had a diagnosis of CFS based on the [[Fukuda criteria]]. Thirty-six age- and gender-matched controls were also included. The conclusions were that in patients with CFS, cardiac magnetic resonance demonstrated lower left ventricle dimensions and a mildly reduced left ventricle function. Heart wall motion abnormalities and the presence of myocardial fibrosis were observed in some CFS patients.<ref name="Olimulder, 2016" />

	Reduced cardiac volumes have been associated with blood volume, but not length of disease.<ref name=":0">{{Cite journal \| last = Blamire \| first = Andrew M. \| authorlink = Andrew Blamire \| last2 = MacGowan \| first2 = Guy \| authorlink2 = Guy ~~McGowan~~ \| last3 = Maclachlan \| first3 = Laura \| authorlink3 = Laura Maclachlan \| last4 = Hodgson \| first4 = Tim \| authorlink4 = Tim Hodgson \| last5 = Frith \| first5 = James \| authorlink5 = James Frith \| last6 = Petrides \| first6 = George \| authorlink6 = George Petrides \| last7 = Finkelmeyer \| first7 = Andreas \| authorlink7 = Andreas Finkelmeyer \| last8 = Newton \| first8 = Julia L. \| authorlink8 = Julia Newton \| date = 2016-06-01 \| title = Reduced cardiac volumes in chronic fatigue syndrome associate with plasma volume but not length of disease: a cohort study \| url = https://openheart.bmj.com/content/3/1/e000381 \| journal = Open Heart\|language=en \| volume = 3 \| issue = 1\| pages = e000381\|doi=10.1136/openhrt-2015-000381\|issn=2053-3624}}</ref>		Reduced cardiac volumes have been associated with blood volume, but not length of disease.<ref name=":0">{{Cite journal \| last = Blamire \| first = Andrew M. \| authorlink = Andrew Blamire \| last2 = MacGowan \| first2 = Guy \| authorlink2 = Guy MacGowan \| last3 = Maclachlan \| first3 = Laura \| authorlink3 = Laura Maclachlan \| last4 = Hodgson \| first4 = Tim \| authorlink4 = Tim Hodgson \| last5 = Frith \| first5 = James \| authorlink5 = James Frith \| last6 = Petrides \| first6 = George \| authorlink6 = George Petrides \| last7 = Finkelmeyer \| first7 = Andreas \| authorlink7 = Andreas Finkelmeyer \| last8 = Newton \| first8 = Julia L. \| authorlink8 = Julia Newton \| date = 2016-06-01 \| title = Reduced cardiac volumes in chronic fatigue syndrome associate with plasma volume but not length of disease: a cohort study \| url = https://openheart.bmj.com/content/3/1/e000381 \| journal = Open Heart\|language=en \| volume = 3 \| issue = 1\| pages = e000381\|doi=10.1136/openhrt-2015-000381\|issn=2053-3624}}</ref>

	A study found that blood volume is a strong physiological correlate of peak oxygen consumption in patients with CFS.<ref name=":1">{{Cite journal \| last = Farquhar \| first = William B. \| authorlink = William Farquhar \| last2 = Hunt \| first2 = Brian E. \| authorlink2 = Brian Hunt \| last3 = Taylor \| first3 = J. Andrew \| authorlink3 = Andrew Taylor \| last4 = Darling \| first4 = Stephen E. \| authorlink4 = Stephen Darling \| last5 = Freeman \| first5 = Roy \| authorlink5 = Roy Freeman \| date = 2002-01-01 \| title = Blood volume and its relation to peak O2consumption and physical activity in patients with chronic fatigue \| url =https://www.physiology.org/doi/full/10.1152/ajpheart.2002.282.1.h66 \| journal = American Journal of Physiology-Heart and Circulatory Physiology \| volume = 282 \| issue = 1\| pages=H66–H71\|doi=10.1152/ajpheart.2002.282.1.H66\|issn=0363-6135}}</ref>		A study found that blood volume is a strong physiological correlate of peak oxygen consumption in patients with CFS.<ref name=":1">{{Cite journal \| last = Farquhar \| first = William B. \| authorlink = William Farquhar \| last2 = Hunt \| first2 = Brian E. \| authorlink2 = Brian Hunt \| last3 = Taylor \| first3 = J. Andrew \| authorlink3 = Andrew Taylor \| last4 = Darling \| first4 = Stephen E. \| authorlink4 = Stephen Darling \| last5 = Freeman \| first5 = Roy \| authorlink5 = Roy Freeman \| date = 2002-01-01 \| title = Blood volume and its relation to peak O2consumption and physical activity in patients with chronic fatigue \| url =https://www.physiology.org/doi/full/10.1152/ajpheart.2002.282.1.h66 \| journal = American Journal of Physiology-Heart and Circulatory Physiology \| volume = 282 \| issue = 1\| pages=H66–H71\|doi=10.1152/ajpheart.2002.282.1.H66\|issn=0363-6135}}</ref>

Svenska:Kardiovaskulära systemet

BeardedBaldy — Thu, 12 Nov 2026 23:19:06 GMT

Translation to swedish.

@@ Line 1: / Line 1: @@
-Det '''kardiovaskulära systemet''', även kallat det kärlsystemet, är ett organsystem som gör det möjligt för [[blood|blodet]] att cirkulera och transportera näringsämnen (t.ex. [[amino acid|aminosyror]] och [[electrolytes|elektrolyter]]), [[sv:Syre|Syre]], koldioxid, [[hormone|hormoner]], och blodkroppar till och från cellerna i kroppen. Det kardiovaskulära systemets uppgift är att tillhandahålla näring och hjälpa till att bekämpa sjukdomar, stabilisera temperatur och pH, och bibehålla [[homeostasis|homeostas]] (balans och stabilitet). Det inkluderar också det [[lymphatic system|lymfatiska systemet]], som cirkulerar [[lymph|lymfa]].
+Det '''kardiovaskulära systemet''', även kallat kärlsystemet, är ett organsystem som gör det möjligt för [[blood|blodet]] att cirkulera och transportera näringsämnen (t.ex. [[amino acid|aminosyror]] och [[electrolytes|elektrolyter]]), [[sv:Syre|Syre]], koldioxid, [[hormone|hormoner]], och blodkroppar till och från cellerna i kroppen. Det kardiovaskulära systemets uppgift är att tillhandahålla näring och hjälpa till att bekämpa sjukdomar, stabilisera temperatur och pH, och bibehålla [[homeostasis|homeostas]] (balans och stabilitet). Det inkluderar också det [[lymphatic system|lymfatiska systemet]], som cirkulerar [[lymph|lymfa]].
 Dysfunktion i det [[sv:Autonoma nervsystemet|autonoma nervsystemet]] som resulterar i [[orthostatic intolerance|ortostatisk intolerans]] (t.ex. [[postural orthostatic tachycardia|postural ortostatisk takykardi]] och [[orthostatic hypotension|ortostatisk hypotoni]]), [[low blood volume|låg blodvolym]], [[preload failure|preloadsvikt]] och andra cirkulationsproblem anses alla bidra till symptomen i [[sv:Myalgisk encefalomyelit|ME]].
 [[Category:Body systems]]
 [[Category:Cardiology]]
 [[Category:Swedish-language articles]]

Colombia

Liface — Thu, 12 Nov 2026 22:38:18 GMT

fixes

@@ Line 1: / Line 1: @@
-{{stub}}
+'''Colombia'''
-==Medical guidelines==
+Colombia has a ME patients association at [http://emsfc.org emsfc.org]. They can also be found on Instagram at [https://www.instagram.com/emsfc_colombia/ @emsfc_colombia].
 == References ==

Svenska:Kardiovaskulära systemet

BeardedBaldy — Thu, 12 Nov 2026 12:01:33 GMT

Started translation to swedish.

New page

Det '''kardiovaskulära systemet''', även kallat det kärlsystemet, är ett organsystem som gör det möjligt för [[blood|blodet]] att cirkulera och transportera näringsämnen (t.ex. [[amino acid|aminosyror]] och [[electrolytes|elektrolyter]]), [[sv:Syre|Syre]], koldioxid, [[hormone|hormoner]], och blodkroppar till och från cellerna i kroppen. Det kardiovaskulära systemets uppgift är att tillhandahålla näring och hjälpa till att bekämpa sjukdomar, stabilisera temperatur och pH, och bibehålla [[homeostasis|homeostas]] (balans och stabilitet). Det inkluderar också det [[lymphatic system|lymfatiska systemet]], som cirkulerar [[lymph|lymfa]].

Dysfunktion i det [[sv:Autonoma nervsystemet|autonoma nervsystemet]] som resulterar i [[orthostatic intolerance|ortostatisk intolerans]] (t.ex. [[postural orthostatic tachycardia|postural ortostatisk takykardi]] och [[orthostatic hypotension|ortostatisk hypotoni]]), [[low blood volume|låg blodvolym]], [[preload failure|preloadsvikt]] och andra cirkulationsproblem anses alla bidra till symptomen i [[sv:Myalgisk encefalomyelit|ME]].

[[Category:Body systems]]
[[Category:Cardiology]]
[[Category:Swedish-language articles]]

Cardiovascular system

BeardedBaldy — Thu, 12 Nov 2026 11:33:19 GMT

← Older revision		Revision as of 11:33, November 12, 2026
(One intermediate revision by the same user not shown)
Line 1:		Line 1:
			{{Language links
			\|page_sv=Kardiovaskulära systemet
			}}
	The '''cardiovascular system''', also called the vascular system, is an organ system that allows [[blood]] to circulate and transport nutrients (such as [[amino acid]]s and [[electrolytes]]), [[oxygen]], carbon dioxide, [[hormone]]s, and [[blood]] cells to and from the cells in the body. The cardiovascular system's purpose is to provide nourishment and help fight diseases, stabilize temperature and pH, and maintain [[homeostasis]]. It also includes includes the [[lymphatic system]], which circulates [[lymph]].		The '''cardiovascular system''', also called the vascular system, is an organ system that allows [[blood]] to circulate and transport nutrients (such as [[amino acid]]s and [[electrolytes]]), [[oxygen]], carbon dioxide, [[hormone]]s, and [[blood]] cells to and from the cells in the body. The cardiovascular system's purpose is to provide nourishment and help fight diseases, stabilize temperature and pH, and maintain [[homeostasis]]. It also includes includes the [[lymphatic system]], which circulates [[lymph]].

Line 41:		Line 44:
	[[Category:Body systems]]		[[Category:Body systems]]
	[[Category:Cardiology]]		[[Category:Cardiology]]
			[[Category:Multilingual pages]]

Svenska:Viktökning

BeardedBaldy — Thu, 12 Nov 2026 09:59:25 GMT

Relocate lang links.

← Older revision		Revision as of 09:59, November 12, 2026
Line 2:		Line 2:

	==Förekomst==		==Förekomst==
	*[[Katrina Berne]] rapporterar en förekomst av 50-70% för viktökning.<ref>{{Cite book \| last = Berne \| first = Katrina \| author-link = Katrina Berne \| date = Dec 1, 1995 \| title = Running on Empty: The Complete Guide to Chronic Fatigue Syndrome (CFIDS)\|edition= 2nd \|url= https://www.amazon.co.uk/Running-Empty-Complete-Chronic-Syndrome/dp/0897931912/ \|publisher= Hunter House \|page = 58 \|isbn= 978-0897931915}}</ref>		*[[sv:Katrina Berne\|Katrina Berne]] rapporterar en förekomst av 50-70% för viktökning.<ref>{{Cite book \| last = Berne \| first = Katrina \| author-link = sv:Katrina Berne \| date = Dec 1, 1995 \| title = Running on Empty: The Complete Guide to Chronic Fatigue Syndrome (CFIDS)\|edition= 2nd \|url= https://www.amazon.co.uk/Running-Empty-Complete-Chronic-Syndrome/dp/0897931912/ \|publisher= Hunter House \|page = 58 \|isbn= 978-0897931915}}</ref>

	==Symptomigenkänning==		==Symptomigenkänning==

Svenska:Viktändring

BeardedBaldy — Thu, 12 Nov 2026 09:58:08 GMT

Relocate lang link.

← Older revision		Revision as of 09:58, November 12, 2026
Line 9:		Line 9:

	==Se även ==		==Se även ==
	*[[~~Weight gain~~\|Viktökning]]		*[[sv:Viktökning\|Viktökning]]
	*[[Weight loss\|Viktminskning]]		*[[Weight loss\|Viktminskning]]
	*[[Anorexia (appetite loss)\|Anorexi (aptitförlust)]]		*[[Anorexia (appetite loss)\|Anorexi (aptitförlust)]]

Svenska:Järn

BeardedBaldy — Thu, 12 Nov 2026 09:56:37 GMT

Relocate lang link.

← Older revision		Revision as of 09:56, November 12, 2026
Line 1:		Line 1:
	{{stub}}		{{stub}}
	'''Järn''' är en väsentlig mineral som används till att skapa [[Red blood cell\|röda blodkroppar]], vilka bär [[~~oxygen~~\|syre]] genom människokroppen.<ref name=":0">{{Cite web \| url = https://www.nhs.uk/conditions/vitamins-and-minerals/iron/ \| title = Vitamins and minerals - Iron \| last = \| first = \| authorlink = \| date = 2017-10-23 \| website = [[National Health Service]]\|language=en\|archive-url=\|archive-date=\|url-status=\|access-date=2022-01-10}}</ref> The main source of iron is food.<ref name=":0" /><ref name="ODS">{{Cite web \| url = https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/ \| title = Iron Fact Sheet for Health Professionals \| last = Gersten \| first = Todd \| authorlink = Todd Gersten \| date = Jun 2, 2020 \| website = Office of Dietary Supplements \| language = en \|archive-url = \| archive-date = \| url-status = \| access-date = 2022-01-10}}</ref>		'''Järn''' är en väsentlig mineral som används till att skapa [[Red blood cell\|röda blodkroppar]], vilka bär [[sv:syre\|syre]] genom människokroppen.<ref name=":0">{{Cite web \| url = https://www.nhs.uk/conditions/vitamins-and-minerals/iron/ \| title = Vitamins and minerals - Iron \| last = \| first = \| authorlink = \| date = 2017-10-23 \| website = [[National Health Service]]\|language=en\|archive-url=\|archive-date=\|url-status=\|access-date=2022-01-10}}</ref> The main source of iron is food.<ref name=":0" /><ref name="ODS">{{Cite web \| url = https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/ \| title = Iron Fact Sheet for Health Professionals \| last = Gersten \| first = Todd \| authorlink = Todd Gersten \| date = Jun 2, 2020 \| website = Office of Dietary Supplements \| language = en \|archive-url = \| archive-date = \| url-status = \| access-date = 2022-01-10}}</ref>

	== Funktion ==		== Funktion ==

Svenska:Kräkning

BeardedBaldy — Thu, 12 Nov 2026 01:03:57 GMT

Relocate lang links.

← Older revision		Revision as of 01:03, November 12, 2026
Line 3:		Line 3:
	==Förekomst==		==Förekomst==

	*[[Katrina Berne~~/sv~~\|Katrina Berne]] rapporterar en förekomst av 20% för kräkningar i [[sv:Kroniskt trötthetssyndrom\|Kroniskt trötthetssyndrom]].<ref>{{Cite book \| last = Berne \| first = Katrina \| author-link = Katrina Berne~~/sv~~ \| date = Dec 1, 1995 \| title = Running on Empty: The Complete Guide to Chronic Fatigue Syndrome (CFIDS)\|edition= 2nd \|url= https://www.amazon.co.uk/Running-Empty-Complete-Chronic-Syndrome/dp/0897931912/ \|publisher= Hunter House \| page = 59 \|isbn= 978-0897931915}}</ref>		*[[sv:Katrina Berne\|Katrina Berne]] rapporterar en förekomst av 20% för kräkningar i [[sv:Kroniskt trötthetssyndrom\|Kroniskt trötthetssyndrom]].<ref>{{Cite book \| last = Berne \| first = Katrina \| author-link = sv:Katrina Berne \| date = Dec 1, 1995 \| title = Running on Empty: The Complete Guide to Chronic Fatigue Syndrome (CFIDS)\|edition= 2nd \|url= https://www.amazon.co.uk/Running-Empty-Complete-Chronic-Syndrome/dp/0897931912/ \|publisher= Hunter House \| page = 59 \|isbn= 978-0897931915}}</ref>

	==Symptomigenkänning==		==Symptomigenkänning==

Svenska:Anosmi

BeardedBaldy — Thu, 12 Nov 2026 00:46:43 GMT

Relocate lang link.

← Older revision		Revision as of 00:46, November 12, 2026
Line 1:		Line 1:
	'''Anosmi''' är förlusten av luktsinnet, [[hyposmia\|hyposmi]] är ett nedsatt luktsinne, [[~~parosmia~~\|parosmi]] är ett förändrat luktsinne, och [[phantosmia\|fantosmi]] är när man känner lukten av något som inte är där.<ref name="JHopkinsSmell-taste"">{{Cite web \| url = https://www.hopkinsmedicine.org/health/conditions-and-diseases/smell-and-taste-disorders \| title = Smell and Taste Disorders \| last = \| first = \| author-link = \| date = \| website = Johns Hopkins Medicine\|language=en\|archive-url=\|archive-date=\|url-status= \| access-date = 2021-12-12}}</ref><ref name="nidcd">{{Cite web \| url = https://www.nidcd.nih.gov/health/smell-disorders \| title = Smell Disorders \| website = NIDCD\|language=en \| access-date = 2021-12-12}}</ref>En förändring av luktsinnet kan förekomma tillsammans med en förändring av [[changes in taste\|smaksinnet]]		'''Anosmi''' är förlusten av luktsinnet, [[hyposmia\|hyposmi]] är ett nedsatt luktsinne, [[sv:parosmi\|parosmi]] är ett förändrat luktsinne, och [[phantosmia\|fantosmi]] är när man känner lukten av något som inte är där.<ref name="JHopkinsSmell-taste"">{{Cite web \| url = https://www.hopkinsmedicine.org/health/conditions-and-diseases/smell-and-taste-disorders \| title = Smell and Taste Disorders \| last = \| first = \| author-link = \| date = \| website = Johns Hopkins Medicine\|language=en\|archive-url=\|archive-date=\|url-status= \| access-date = 2021-12-12}}</ref><ref name="nidcd">{{Cite web \| url = https://www.nidcd.nih.gov/health/smell-disorders \| title = Smell Disorders \| website = NIDCD\|language=en \| access-date = 2021-12-12}}</ref>En förändring av luktsinnet kan förekomma tillsammans med en förändring av [[changes in taste\|smaksinnet]]

	==ME/CFS==		==ME/CFS==

Svenska:Dysfagi

BeardedBaldy — Thu, 12 Nov 2026 00:45:42 GMT

Relocate lang links.

← Older revision		Revision as of 00:45, November 12, 2026
Line 5:		Line 5:

	==Förekomst==		==Förekomst==
	*[[Katrina Berne]] rapporterar en förekomst på 55-60% av svårigheter att svälja.<ref>{{Cite book \| last = Berne \| first = Katrina \| author-link = Katrina Berne \| date = Dec 1, 1995 \| title = Running on Empty: The Complete Guide to Chronic Fatigue Syndrome (CFIDS)\|edition= 2nd \|url= https://www.amazon.co.uk/Running-Empty-Complete-Chronic-Syndrome/dp/0897931912/ \| publisher = Hunter House \| page = 58 \|isbn= 978-0897931915}}</ref>		*[[sv:Katrina Berne\|Katrina Berne]] rapporterar en förekomst på 55-60% av svårigheter att svälja.<ref>{{Cite book \| last = Berne \| first = Katrina \| author-link = sv:Katrina Berne \| date = Dec 1, 1995 \| title = Running on Empty: The Complete Guide to Chronic Fatigue Syndrome (CFIDS)\|edition= 2nd \|url= https://www.amazon.co.uk/Running-Empty-Complete-Chronic-Syndrome/dp/0897931912/ \| publisher = Hunter House \| page = 58 \|isbn= 978-0897931915}}</ref>

	==Symptomigenkänning==		==Symptomigenkänning==

Svenska:Postinfektiöst trötthetssyndrom

BeardedBaldy — Thu, 12 Nov 2026 00:44:17 GMT

Relocate lang link.

← Older revision		Revision as of 00:44, November 12, 2026
Line 20:		Line 20:

	==Vidare läsning ==		==Vidare läsning ==
	*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1293107/pdf/jrsocmed00127-0072.pdf A report - chronic fatigue syndrome: guidelines for research] - The "Oxford criteria" - ''Journal of the Royal Society of Medicine'' - Volume 84 February 1991 118-121<ref name="Oxfordcriteria">{{Cite journal\|url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1293107/\| title = A report - chronic fatigue syndrome: guidelines for research\|journal=Journal of the Royal Society of Medicine\|volume=84 \| date = Feb 1991\|pages=118-121\|pmc = 1293107 \| author-link = Michael Sharpe \| first1 = Michael \| last1 = Sharpe \| first2 = Len \| last2 = Archard \| authorlink2 = Len Archard \| first3 = Jangu \| last3 = Banatvala \| authorlink3 = Jangu Banatvala \| first4 = Leszek \| last4 = Borysiewicz \| authorlink4 = Leszek Borysiewicz \| first5 = Anthony \| last5 = Cleare \| authorlink5 = Anthony Cleare \| first6 = Anthony \| last6 = David \| authorlink6 = Anthony David \| first7 = Richard \| last7 = Edwards \| authorlink7 = sv:Richard Edwards \| first8 = Keith \| last8 = Hawton \| authorlink8 = Keith Hawton \| first9 = Harold \| last9 = Lambert \| authorlink9 = Harold Lambert \| first10 = Russell \| last10 = Lane \| authorlink10 = Russel Lane}}</ref>		*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1293107/pdf/jrsocmed00127-0072.pdf A report - chronic fatigue syndrome: guidelines for research] - The "Oxford criteria" - ''Journal of the Royal Society of Medicine'' - Volume 84 February 1991 118-121<ref name="Oxfordcriteria">{{Cite journal\|url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1293107/\| title = A report - chronic fatigue syndrome: guidelines for research\|journal=Journal of the Royal Society of Medicine\|volume=84 \| date = Feb 1991\|pages=118-121\|pmc = 1293107 \| author-link = Michael Sharpe \| first1 = Michael \| last1 = Sharpe \| first2 = Len \| last2 = Archard \| authorlink2 = Len Archard \| first3 = Jangu \| last3 = Banatvala \| authorlink3 = Jangu Banatvala \| first4 = Leszek \| last4 = Borysiewicz \| authorlink4 = sv:Leszek Borysiewicz \| first5 = Anthony \| last5 = Cleare \| authorlink5 = Anthony Cleare \| first6 = Anthony \| last6 = David \| authorlink6 = Anthony David \| first7 = Richard \| last7 = Edwards \| authorlink7 = sv:Richard Edwards \| first8 = Keith \| last8 = Hawton \| authorlink8 = Keith Hawton \| first9 = Harold \| last9 = Lambert \| authorlink9 = Harold Lambert \| first10 = Russell \| last10 = Lane \| authorlink10 = Russel Lane}}</ref>

	==Referenser==		==Referenser==

1936 Fond-du-Lac outbreak

BeardedBaldy — Wed, 11 Nov 2026 23:41:47 GMT

Added authorlinks. Updated url in ref. Corrected date of publication in ref.

← Older revision		Revision as of 23:41, November 11, 2026
Line 1:		Line 1:
	== Onset ==		== Onset ==
	An early recorded outbreak of ME was in Fond-du-Lac, Wisconsin, US. Recorded by the US Public Health Service,<ref name="Fond-du-Lac">{{citation \| last =Armstong \| first = Charles A. \| title = Report to the Surgeon General, US Public Health Service, of the investigation of an outbreak of "Encephalitis" in the St. Agnes Convent, Fond-du-Lac, Wisconsin. \| date = 1936}}</ref> the outbreak struck Saint Agnes Convent and was recorded as "encephalitis".<ref name="Hydebook">{{Cite book \| title = The Clinical and scientific basis of myalgic encephalomyelitis/chronic fatigue syndrome \| last = Hyde \| first = Byron \| publisher = Nightingale Research Foundation\| year = 1992\|isbn=0969566204\|location=Ogdensburg, NY \| pages = X}}</ref><ref name="NewYorker1965">{{Cite news \| publisher = The New Yorker \|volume =41 \|issue =Part 6\| page =208 \| title = In The Bughouse \| date = Nov 19, 1965 \| last = Roueché \| first = Berton \| url = ~~http~~://www.newyorker.com/magazine/1965/11/27/in-the-bughouse }}</ref> Fifty-three young women were infected, all novices and convent candidates<ref>{{Cite book \| title = Medical Etiology, Assessment, and Treatment of Chronic Fatigue and Malaise \| last = Patarca-Montero \| first = Roberto\| publisher = Haworth Press\| year = 2004\|isbn=078902196X\|location= \| pages = 6-7}}</ref>		An early recorded outbreak of ME was in Fond-du-Lac, Wisconsin, US. Recorded by the US Public Health Service,<ref name="Fond-du-Lac">{{citation \| last =Armstong \| first = Charles A. \| title = Report to the Surgeon General, US Public Health Service, of the investigation of an outbreak of "Encephalitis" in the St. Agnes Convent, Fond-du-Lac, Wisconsin. \| date = 1936}}</ref> the outbreak struck Saint Agnes Convent and was recorded as "encephalitis".<ref name="Hydebook">{{Cite book \| title = The Clinical and scientific basis of myalgic encephalomyelitis/chronic fatigue syndrome \| last = Hyde \| first = Byron \| authorlink = Byron Hyde \| publisher = Nightingale Research Foundation\| year = 1992\|isbn=0969566204\|location=Ogdensburg, NY \| pages = X}}</ref><ref name="NewYorker1965">{{Cite news \| publisher = The New Yorker \|volume =41 \|issue =Part 6\| page =208 \| title = In The Bughouse \| date = Nov 20, 1965 \| last = Roueché \| first = Berton \| authorlink = Berton Roueché \| url = https://www.newyorker.com/magazine/1965/11/27/in-the-bughouse }}</ref> Fifty-three young women were infected, all novices and convent candidates<ref>{{Cite book \| title = Medical Etiology, Assessment, and Treatment of Chronic Fatigue and Malaise \| last = Patarca-Montero \| first = Roberto\| publisher = Haworth Press\| year = 2004\|isbn=078902196X\|location= \| pages = 6-7}}</ref>

	== Symptoms ==		== Symptoms ==
Line 13:		Line 13:
	*limb pain		*limb pain
	*[[sore throat]] (prodomal)		*[[sore throat]] (prodomal)
	*fatiguability/malaise<ref name="Henderson1959">{{Cite journal \| title = Epidemic Neuromyasthenia - Clinical Syndrome?\|url = https://www.nejm.org/doi/pdf/10.1056/NEJM195904092601506 \| last = Henderson \| first = Donald A. \| last2 =Shelokov \| first2 =Alexis \| date =April 9, 1959\|journal =N Engl J Med \|volume = 260 \|issue =15 \| pages = 757-764\|doi= 10.1056/NEJM195904092601506}} </ref>		*fatiguability/malaise<ref name="Henderson1959">{{Cite journal \| title = Epidemic Neuromyasthenia - Clinical Syndrome? \| url = https://www.nejm.org/doi/pdf/10.1056/NEJM195904092601506 \| last = Henderson \| first = Donald A. \| authorlink = Donald Henderson \| last2 = Shelokov \| first2 = Alexis \| authorlink2 = Alexis Shelokov \| date = April 9, 1959 \| journal = N Engl J Med \|volume = 260 \|issue = 15 \| pages = 757-764 \| doi = 10.1056/NEJM195904092601506}} </ref>

	== Findings ==		== Findings ==

Svenska:Lista över utbrott av myalgisk encefalomyelit och kroniskt trötthetssyndrom

BeardedBaldy — Wed, 11 Nov 2026 23:23:17 GMT

Removed "||".

← Older revision		Revision as of 23:23, November 11, 2026
Line 6:		Line 6:
	=== 1930-talet ===		=== 1930-talet ===

	==== [[1934 Los Angeles atypical polio outbreak\|1934 - Los Angeles, USA\|\|]] ====		==== [[1934 Los Angeles atypical polio outbreak\|1934 - Los Angeles, USA]] ====
	Epidemi bland personal på L.A. County Hospital, Ruth Protection Home och genom hela kalifornien, parallellt med polio, ofta diagnostiserad som atypisk polio, ibland inkluderande ledsjukdom.<ref name="Gilliam, 1936-38">{{Cite journal \| last = Gilliam \| first1 = A.G. \| authorlink1 = \| title = Epidemiological Study Of An Epidemic, Diagnosed As Poliomyelitis, Occurring Among The Personnel Of The Los Angeles County General Hospital During The Summer Of 1934\| journal = Public health bulletin, 1936-1938 \| volume = \| issue = \| pages = 231-240\| date = 1938 \| pmid = \| url = http://babel.hathitrust.org/cgi/pt?id=mdp.39015022082260;view=1up;seq=617 }}</ref>		Epidemi bland personal på L.A. County Hospital, Ruth Protection Home och genom hela kalifornien, parallellt med polio, ofta diagnostiserad som atypisk polio, ibland inkluderande ledsjukdom.<ref name="Gilliam, 1936-38">{{Cite journal \| last = Gilliam \| first1 = A.G. \| authorlink1 = \| title = Epidemiological Study Of An Epidemic, Diagnosed As Poliomyelitis, Occurring Among The Personnel Of The Los Angeles County General Hospital During The Summer Of 1934\| journal = Public health bulletin, 1936-1938 \| volume = \| issue = \| pages = 231-240\| date = 1938 \| pmid = \| url = http://babel.hathitrust.org/cgi/pt?id=mdp.39015022082260;view=1up;seq=617 }}</ref>

Endocrine system

BeardedBaldy — Wed, 11 Nov 2026 23:16:01 GMT

Added authorlinks in refs.

← Older revision		Revision as of 23:16, November 11, 2026
Line 14:		Line 14:

	=== Pituitary ===		=== Pituitary ===
	The [[pituitary gland]] is a small bulb situated at the base of the brain and both releases hormones and controls other glands which release hormones. It is under direct control of the [[hypothalamus]], a section of the [[brain]] right above the pituitary.<ref>{{Cite news \|url =https://www.merckmanuals.com/home/hormonal-and-metabolic-disorders/pituitary-gland-disorders/overview-of-the-pituitary-gland \| title = Overview of the Pituitary Gland - Hormonal and Metabolic Disorders\|work=Merck Manuals Consumer Version\|access-date=2018-10-18\|language=en-US}}</ref> The hypothalamus receives input about hormonal and homeostatic states in the body, processes that information, then relays instructions to the pituitary gland to respond with certain hormones.<ref name="DoughertyCh">{{Cite book \|chapter-url=https://nba.uth.tmc.edu/neuroscience/m/s4/chapter01.html\|chapter=Hypothalamus: Structural Organization \| url =https://nba.uth.tmc.edu/neuroscience/m/s4/index.htm \| title = Neuroscience Online: An Electronic Textbook for the Neurosciences \| last = Dougherty \| first = Patrick\|website=McGovern Medical School - The University of Texas Medical School at Houston\|access-date=2020-10-20}}</ref> For example, osmoreceptors, water-level sensing cells, in the hypothalamus detect when you are dehydrated. The hypothalamus tells the pituitary to release antidiuretic hormone, which notifies the bladder to retain water. Water levels in the body will increase and once at an adequate level the osmoreceptors stop their signaling to have ADH released<ref name=":1">{{Cite web \| url=https://courses.lumenlearning.com/suny-ap2/chapter/the-pituitary-gland-and-hypothalamus/ \| title = The Pituitary Gland and Hypothalamus {{!}} Anatomy and Physiology II\|website=courses.lumenlearning.com\|access-date=2018-10-18}}</ref>.		The [[pituitary gland]] is a small bulb situated at the base of the brain and both releases hormones and controls other glands which release hormones. It is under direct control of the [[hypothalamus]], a section of the [[brain]] right above the pituitary.<ref>{{Cite news \|url =https://www.merckmanuals.com/home/hormonal-and-metabolic-disorders/pituitary-gland-disorders/overview-of-the-pituitary-gland \| title = Overview of the Pituitary Gland - Hormonal and Metabolic Disorders\|work=Merck Manuals Consumer Version\|access-date=2018-10-18\|language=en-US}}</ref> The hypothalamus receives input about hormonal and homeostatic states in the body, processes that information, then relays instructions to the pituitary gland to respond with certain hormones.<ref name="DoughertyCh">{{Cite book \|chapter-url=https://nba.uth.tmc.edu/neuroscience/m/s4/chapter01.html\|chapter=Hypothalamus: Structural Organization \| url =https://nba.uth.tmc.edu/neuroscience/m/s4/index.htm \| title = Neuroscience Online: An Electronic Textbook for the Neurosciences \| last = Dougherty \| first = Patrick \| authorlink = Patrick Dougherty \| website=McGovern Medical School - The University of Texas Medical School at Houston\|access-date=2020-10-20}}</ref> For example, osmoreceptors, water-level sensing cells, in the hypothalamus detect when you are dehydrated. The hypothalamus tells the pituitary to release antidiuretic hormone, which notifies the bladder to retain water. Water levels in the body will increase and once at an adequate level the osmoreceptors stop their signaling to have ADH released<ref name=":1">{{Cite web \| url=https://courses.lumenlearning.com/suny-ap2/chapter/the-pituitary-gland-and-hypothalamus/ \| title = The Pituitary Gland and Hypothalamus {{!}} Anatomy and Physiology II\|website=courses.lumenlearning.com\|access-date=2018-10-18}}</ref>.

	{\| class="wikitable"		{\| class="wikitable"
Line 40:		Line 40:

	=== Hypothalamus ===		=== Hypothalamus ===
	The [[hypothalamus]] maintains homeostasis in the body. It receives input from sources such as the vagus nerve (which can relay information about blood pressure and stomach fullness), the optic nerve (which relays levels of light), receptors in the body and skin (which relay temperature), and even has its own receptors which inform about the amount of molecules in the blood<ref>{{Cite web \| url=http://webspace.ship.edu/cgboer/limbicsystem.html \| title = The Limbic System \| last = Boeree \| first = George\|website=webspace.ship.edu\|access-date=2018-10-18}}</ref> (which relays if there is an unbalanced ratio of fluid to molecules).		The [[hypothalamus]] maintains homeostasis in the body. It receives input from sources such as the vagus nerve (which can relay information about blood pressure and stomach fullness), the optic nerve (which relays levels of light), receptors in the body and skin (which relay temperature), and even has its own receptors which inform about the amount of molecules in the blood<ref>{{Cite web \| url=http://webspace.ship.edu/cgboer/limbicsystem.html \| title = The Limbic System \| last = Boeree \| first = George \| authorlink = George Boeree \| website=webspace.ship.edu\|access-date=2018-10-18}}</ref> (which relays if there is an unbalanced ratio of fluid to molecules).

	When the hypothalamus is not functioning properly, many systems become dysregulated. This dysfunction can be caused by a number of different triggers such as an eating disorder, a tumor, brain injury or genetic mutations<ref>{{Cite web \| url=https://rarediseases.info.nih.gov/diseases/2932/hypothalamic-dysfunction \| title = Hypothalamic dysfunction {{!}} Genetic and Rare Diseases Information Center (GARD) – an NCATS Program\|website=rarediseases.info.nih.gov\|language=en\|access-date=2018-10-18}}</ref>. A malfunctioning hypothalamus alters motivations to drink, eat and copulate which can lead to malnutrition or overeating, dehydration or overhydration and decreased or increased sexual behavior. Sleep patterns, activity levels, and menstruation may also change<ref>{{Cite web \| url=https://www.braininjury-explanation.com/consequences/impact-by-brain-area/hypothalamus \| title = Hypothalamus / Impact per brain area / Consequences {{!}} Braininjury-explanation.com \| website = braininjury-explanation.com\|language=\|access-date=2018-10-18}}</ref>.		When the hypothalamus is not functioning properly, many systems become dysregulated. This dysfunction can be caused by a number of different triggers such as an eating disorder, a tumor, brain injury or genetic mutations<ref>{{Cite web \| url=https://rarediseases.info.nih.gov/diseases/2932/hypothalamic-dysfunction \| title = Hypothalamic dysfunction {{!}} Genetic and Rare Diseases Information Center (GARD) – an NCATS Program\|website=rarediseases.info.nih.gov\|language=en\|access-date=2018-10-18}}</ref>. A malfunctioning hypothalamus alters motivations to drink, eat and copulate which can lead to malnutrition or overeating, dehydration or overhydration and decreased or increased sexual behavior. Sleep patterns, activity levels, and menstruation may also change<ref>{{Cite web \| url=https://www.braininjury-explanation.com/consequences/impact-by-brain-area/hypothalamus \| title = Hypothalamus / Impact per brain area / Consequences {{!}} Braininjury-explanation.com \| website = braininjury-explanation.com\|language=\|access-date=2018-10-18}}</ref>.
Line 50:		Line 50:

	==Relationship to ME/CFS ==		==Relationship to ME/CFS ==
	[[Hypothalamic-pituitary-adrenal axis]] (HPA) is the collaborative functioning between the hypothalamus and the pituitary gland. These tissues work together to regulate hormone production and release, and also moderate bodily functions such as temperature regulation, fluid balance, appetite and thirst detection. Hypofunction of the HPA has been identified as a problem experienced in [[ME/CFS]] patients. Lower cortisol levels were identified in ME/CFS patients than in healthy controls, and has been shown to be connected to [[Sleep dysfunction\|decreased sleep]]<ref>{{Cite journal \| last = Nijhof \| first = Sanne L. \| last2 = Rutten \| first2 = Juliette M. T.M. \| last3 = Uiterwaal \| first3 = Cuno S. P.M. \| last4 = Bleijenberg \| first4 = Gijs \| last5 = Kimpen \| first5 = Jan L.L. \| last6 = Putte \| first6 = Elise M. van de \| date = Apr 2014 \| title = The role of hypocortisolism in chronic fatigue syndrome \| url =https://www.ncbi.nlm.nih.gov/pubmed/24636516\|journal=Psychoneuroendocrinology\|volume=42 \| pages = 199–206\|doi=10.1016/j.psyneuen.2014.01.017\|issn=1873-3360\|pmid=24636516}}</ref>. Exogenous [[cortisol]] administration was tested as a possible treatment however these results should be replicated due to the group’s use of solely the [[Fukuda criteria\|Fukuda]] Assessment of ME/CFS (which may allow for error in diagnosis of the condition). Furthermore, several journals suggested [[Cognitive behavioral therapy\|CBT]] as a feasible treatment option to increase cortisol levels, however due to the extensive literature questioning and undermining the utility of CBT in ME/CFS in overall treatment, other options should be explored in this research.<ref>{{Cite journal \| last = Twisk \| first = Frank N.M. \| last2 = Maes \| first2 = Michael \| date = 2009 \| title = A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS\| url = https://www.ncbi.nlm.nih.gov/pubmed/19855350\|journal=Neuro Endocrinology Letters\|volume=30\|issue=3 \| pages = 284–299\|issn=0172-780X\|pmid=19855350}}</ref><ref>{{Cite journal \| last = Núñez \| first = Montserrat \| last2 = Fernández-Solà \| first2 = Joaquim \| last3 = Nuñez \| first3 = Esther \| last4 = Fernández-Huerta \| first4 = José-Manuel \| last5 = Godás-Sieso \| first5 = Teresa \| last6 = Gomez-Gil \| first6 = Esther \| date = 2011-01-15 \| title = Health-related quality of life in patients with chronic fatigue syndrome: group cognitive behavioural therapy and graded exercise versus usual treatment. A randomised controlled trial with 1 year of follow-up \| url =https://link.springer.com/article/10.1007/s10067-010-1677-y\|journal=Clinical Rheumatology\|language=en\|volume=30\|issue=3 \| pages = 381–389\|doi=10.1007/s10067-010-1677-y\|issn=0770-3198}}</ref>		[[Hypothalamic-pituitary-adrenal axis]] (HPA) is the collaborative functioning between the hypothalamus and the pituitary gland. These tissues work together to regulate hormone production and release, and also moderate bodily functions such as temperature regulation, fluid balance, appetite and thirst detection. Hypofunction of the HPA has been identified as a problem experienced in [[ME/CFS]] patients. Lower cortisol levels were identified in ME/CFS patients than in healthy controls, and has been shown to be connected to [[Sleep dysfunction\|decreased sleep]]<ref>{{Cite journal \| last = Nijhof \| first = Sanne L. \| last2 = Rutten \| first2 = Juliette M. T.M. \| last3 = Uiterwaal \| first3 = Cuno S. P.M. \| last4 = Bleijenberg \| first4 = Gijs \| last5 = Kimpen \| first5 = Jan L.L. \| last6 = Putte \| first6 = Elise M. van de \| date = Apr 2014 \| title = The role of hypocortisolism in chronic fatigue syndrome \| url =https://www.ncbi.nlm.nih.gov/pubmed/24636516\|journal=Psychoneuroendocrinology\|volume=42 \| pages = 199–206\|doi=10.1016/j.psyneuen.2014.01.017\|issn=1873-3360\|pmid=24636516}}</ref>. Exogenous [[cortisol]] administration was tested as a possible treatment however these results should be replicated due to the group’s use of solely the [[Fukuda criteria\|Fukuda]] Assessment of ME/CFS (which may allow for error in diagnosis of the condition). Furthermore, several journals suggested [[Cognitive behavioral therapy\|CBT]] as a feasible treatment option to increase cortisol levels, however due to the extensive literature questioning and undermining the utility of CBT in ME/CFS in overall treatment, other options should be explored in this research.<ref>{{Cite journal \| last = Twisk \| first = Frank N.M. \| authorlink = Frank Twisk \| last2 = Maes \| first2 = Michael \| authorlink2 = Michael Maes \| date = 2009 \| title = A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS\| url = https://www.ncbi.nlm.nih.gov/pubmed/19855350\|journal=Neuro Endocrinology Letters\|volume=30\|issue=3 \| pages = 284–299\|issn=0172-780X\|pmid=19855350}}</ref><ref>{{Cite journal \| last = Núñez \| first = Montserrat \| last2 = Fernández-Solà \| first2 = Joaquim \| last3 = Nuñez \| first3 = Esther \| last4 = Fernández-Huerta \| first4 = José-Manuel \| last5 = Godás-Sieso \| first5 = Teresa \| last6 = Gomez-Gil \| first6 = Esther \| date = 2011-01-15 \| title = Health-related quality of life in patients with chronic fatigue syndrome: group cognitive behavioural therapy and graded exercise versus usual treatment. A randomised controlled trial with 1 year of follow-up \| url =https://link.springer.com/article/10.1007/s10067-010-1677-y\|journal=Clinical Rheumatology\|language=en\|volume=30\|issue=3 \| pages = 381–389\|doi=10.1007/s10067-010-1677-y\|issn=0770-3198}}</ref>

	==See also ==		==See also ==

← Older revision		Revision as of 23:34, November 13, 2026
Line 61:		Line 61:
	{{Main article \|page_name =Onset of ME/CFS}}		{{Main article \|page_name =Onset of ME/CFS}}

	Enligt Dr [[Byron Hyde]], efter en inkubationstid av 4 till 7 dagar, medför generellt prodromalfasen en [[sv:Influensaliknande sjukdom\|influensaliknande sjukdom]] med [[~~low-grade fever~~\|låggradig feber]].<ref name="Evans2018" /> I de flesta, men inte alla, fall är en [[infection\|infektion]] eller infektionsprocess uppenbar.<ref name="Evans2018">{{Cite journal \| last = Evans \| first = Meredyth \| authorlink = Meredyth Evans \| last2 = Jason \| first2 =Leonard \| authorlink2 = Leonard Jason \| date = 2018 \| title = Onset patterns of chronic fatigue syndrome and myalgic encephalomyelitis\|url=https://www.openaccessjournals.com/articles/Onset%20patterns%20of%20chronic%20fatigue%20syndrome%20and%20myalgic%20encephalomyelitis.pdf \| journal=Research on Chronic diseases\|volume=2\|issue=1\|pages=2-3\|quote=\|via=}}</ref> Två till sju dagar senare, påbörjas en kronisk fas, kännetecknad av en mätbar oklar förändring i funktionen av det centrala nervsystemet. Det är denna andra, ihållande fas som mest kännetecknar ME.<ref name="Nightingale">{{Citation \| title = The Nightingale Research Foundation Definition of Myalgic Encephalomyelitis (M.E.)\|pages=\|language=en\|title-link=Nightingale Research Foundation definition \| date = 2016 \| publisher=IACFS/ME \| last = Hyde \| first = Byron \| authorlink = Byron Hyde\|others=\|oclc=\|quote=\|location=}}</ref><ref name="Evans2018" />		Enligt Dr [[Byron Hyde]], efter en inkubationstid av 4 till 7 dagar, medför generellt prodromalfasen en [[sv:Influensaliknande sjukdom\|influensaliknande sjukdom]] med [[sv:låggradig feber\|låggradig feber]].<ref name="Evans2018" /> I de flesta, men inte alla, fall är en [[infection\|infektion]] eller infektionsprocess uppenbar.<ref name="Evans2018">{{Cite journal \| last = Evans \| first = Meredyth \| authorlink = Meredyth Evans \| last2 = Jason \| first2 =Leonard \| authorlink2 = Leonard Jason \| date = 2018 \| title = Onset patterns of chronic fatigue syndrome and myalgic encephalomyelitis\|url=https://www.openaccessjournals.com/articles/Onset%20patterns%20of%20chronic%20fatigue%20syndrome%20and%20myalgic%20encephalomyelitis.pdf \| journal=Research on Chronic diseases\|volume=2\|issue=1\|pages=2-3\|quote=\|via=}}</ref> Två till sju dagar senare, påbörjas en kronisk fas, kännetecknad av en mätbar oklar förändring i funktionen av det centrala nervsystemet. Det är denna andra, ihållande fas som mest kännetecknar ME.<ref name="Nightingale">{{Citation \| title = The Nightingale Research Foundation Definition of Myalgic Encephalomyelitis (M.E.)\|pages=\|language=en\|title-link=Nightingale Research Foundation definition \| date = 2016 \| publisher=IACFS/ME \| last = Hyde \| first = Byron \| authorlink = Byron Hyde\|others=\|oclc=\|quote=\|location=}}</ref><ref name="Evans2018" />

	==Tecken och symptom==		==Tecken och symptom==
Line 72:		Line 72:
	* [[gastrointestinal\|gastrointestinala]] symptom		* [[gastrointestinal\|gastrointestinala]] symptom
	* [[headache\|huvudvärk]]		* [[headache\|huvudvärk]]
	*[[~~low-grade fever~~\|låggradig feber]], [[Temperature dysregulation\|temperatur instabilitet]]		*[[sv:låggradig feber\|låggradig feber]], [[Temperature dysregulation\|temperatur instabilitet]]
	*[[muscle\|muskel]] [[Muscle weakness\|svag]]- och [[Muscle fatigability\|trötthet]]		*[[muscle\|muskel]] [[Muscle weakness\|svag]]- och [[Muscle fatigability\|trötthet]]
	*[[myalgia\|myalgi (muskelsmärta)]]		*[[myalgia\|myalgi (muskelsmärta)]]

← Older revision		Revision as of 22:26, November 13, 2026
Line 1:		Line 1:
	[[File:ME CFS symptoms CCC.png\|frameless\|upright = 0.75\|right\|Simplified Canadian Consensus Criteria for ME/CFS.]]		[[File:ME CFS symptoms CCC.png\|frameless\|upright = 0.75\|right\|Simplified Canadian Consensus Criteria for ME/CFS.]]
	The [[Canadian Consensus Criteria\|Canadian consensus criteria]] (CCC) or the '''Canadian working definition''' are a proposed clinical criteria for [[ME/CFS]], published in 2003, and frequently used as a case definition in research.<ref name="Carruthers, 2003">{{Citation \| last1 = Carruthers \| first1 = Bruce M. \| author-link1 = Bruce Carruthers \| last2 = Jain \| first2 = Anil Kumar \| author-link2 = Anil Kumar Jain \| last3 = De Meirleir \| first3 = Kenny L. \| author-link3 = Kenny De Meirleir \| last4 = Peterson \| first4 = Daniel L. \| author-link4 = Daniel Peterson \| last5 = Klimas \| first5 = Nancy G. \| author-link5 = Nancy Klimas \| last6 = Lerner \| first6 = A. Martin \| author-link6 = Martin Lerner \| last7 = Bested \| first7 = Alison C. \| author-link7 = Alison Bested \| last8 = Flor-Henry \| first8 = Pierre \| author-link8 = Pierre Flor-Henry \| last9 = Joshi \| first9 = Pradip \| author-link9 = Pradip Joshi \| last10 = Powles \| first10 = AC Peter \| author-link10 = A C Peter Powles \| last11 = Sherkey \| first11 = Jeffrey A. \| author-link11 = Jeffrey Sherkey \| last12 = van de Sande \| first12 = Marjorie I. \| author-link12 = Marjorie van de Sande \| title = Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols \| journal = Journal of Chronic Fatigue Syndrome \| volume = 11 \| issue = 2 \| pages = 7-115 \| date = 2003 \| pmid = \| doi = 10.1300/J092v11n01_02 \| url = http://www.meresearch.org.uk/wp-content/uploads/2012/11/2003-Carruthers-Canadian-Definition-JCFS.pdf }}</ref> The Canadian definition is a strictest diagnostic criteria, selecting a smaller group of patients than the [[Fukuda criteria]] and a more severely impaired population.<ref>http://www.meaction.net/2015/12/10/norwegian-researchers-ask-what-exactly-is-m-e/</ref> Adults are diagnosed after a minimum of six months of illness and children after a minimum of three months.		The [[Canadian Consensus Criteria\|Canadian consensus criteria]] (CCC) or the '''Canadian working definition''' are a proposed clinical criteria for [[ME/CFS]], published in 2003, and frequently used as a case definition in research.<ref name="Carruthers, 2003">{{Citation \| last1 = Carruthers \| first1 = Bruce M. \| author-link1 = Bruce Carruthers \| last2 = Jain \| first2 = Anil Kumar \| author-link2 = Anil Kumar Jain \| last3 = De Meirleir \| first3 = Kenny L. \| author-link3 = Kenny De Meirleir \| last4 = Peterson \| first4 = Daniel L. \| author-link4 = Daniel Peterson \| last5 = Klimas \| first5 = Nancy G. \| author-link5 = Nancy Klimas \| last6 = Lerner \| first6 = A. Martin \| author-link6 = Martin Lerner \| last7 = Bested \| first7 = Alison C. \| author-link7 = Alison Bested \| last8 = Flor-Henry \| first8 = Pierre \| author-link8 = Pierre Flor-Henry \| last9 = Joshi \| first9 = Pradip \| author-link9 = Pradip Joshi \| last10 = Powles \| first10 = AC Peter \| author-link10 = A C Peter Powles \| last11 = Sherkey \| first11 = Jeffrey A. \| author-link11 = Jeffrey Sherkey \| last12 = van de Sande \| first12 = Marjorie I. \| author-link12 = Marjorie van de Sande \| title = Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols \| journal = Journal of Chronic Fatigue Syndrome \| volume = 11 \| issue = 2 \| pages = 7-115 \| date = 2003 \| pmid = \| doi = 10.1300/J092v11n01_02 \| url = http://www.meresearch.org.uk/wp-content/uploads/2012/11/2003-Carruthers-Canadian-Definition-JCFS.pdf }}</ref> The Canadian definition is the strictest diagnostic criteria, selecting a smaller group of patients than the [[Fukuda criteria]] and a more severely impaired population.<ref>http://www.meaction.net/2015/12/10/norwegian-researchers-ask-what-exactly-is-m-e/</ref> Adults are diagnosed after a minimum of six months of illness and children after a minimum of three months.

	==Definition==		==Definition==
Line 52:		Line 52:
	* [[thermostatic instability\|Loss of thermostatic stability]] ([[subnormal body temperature]] and marked [[diurnal fluctuation]])		* [[thermostatic instability\|Loss of thermostatic stability]] ([[subnormal body temperature]] and marked [[diurnal fluctuation]])
	* [[Sweating episodes]], recurrent feelings of [[low-grade fever\|feverishness]]		* [[Sweating episodes]], recurrent feelings of [[low-grade fever\|feverishness]]
	* [[cold hands and feet\|cold extremities]] (cold ~~hand~~ and feet)		* [[cold hands and feet\|cold extremities]] (cold hands and feet)
	* [[temperature sensitivity\|Intolerance of extremes of heat and cold]]		* [[temperature sensitivity\|Intolerance of extremes of heat and cold]]
	* Marked [[weight change]] ([[Anorexia (appetite loss)\|anorexia]] or [[abnormal appetite]])		* Marked [[weight change]] ([[Anorexia (appetite loss)\|anorexia]] or [[abnormal appetite]])

← Older revision		Revision as of 00:07, November 13, 2026
Line 3:		Line 3:
	[[File:Jenny Spotlia.jpg\|300px\|thumb\|right\|[[Jennie Spotila]] är en amerikansk ME patient som insjuknade den 6e Oktober 1994. Jennie är [[Severe and very severe ME\|handikappad, mestadels hembunden, och använder en rullstol]] men har varit en [[sv:ME/CFS\|ME/CFS]] förespråkare i många år. Hon skriver bloggen [[Occupy M.E.]] Hon tjänade satt i styrelsen för [[Solve ME/CFS Initiative\|CFIDS Association of America]] (Amerikas CFIDS Förbund) och vittnade inför [[Chronic Fatigue Syndrome Advisory Committee\|CFSAC]]]]		[[File:Jenny Spotlia.jpg\|300px\|thumb\|right\|[[Jennie Spotila]] är en amerikansk ME patient som insjuknade den 6e Oktober 1994. Jennie är [[Severe and very severe ME\|handikappad, mestadels hembunden, och använder en rullstol]] men har varit en [[sv:ME/CFS\|ME/CFS]] förespråkare i många år. Hon skriver bloggen [[Occupy M.E.]] Hon tjänade satt i styrelsen för [[Solve ME/CFS Initiative\|CFIDS Association of America]] (Amerikas CFIDS Förbund) och vittnade inför [[Chronic Fatigue Syndrome Advisory Committee\|CFSAC]]]]

	'''Myalgisk encefalomyelit''' (ME) är en kronisk, [[sv:Inflammation\|inflammatorisk]], fysisk och [[sv:Nervsystem\|neurologisk]] och immun-förmedlad sjukdom med symptom som involverar många kroppssystem. Den blir ofta utlöst av en [[sv:Virusinfektion\|virusinfektion]] eller en [[sv:Influensaliknande sjukdom\|influensaliknande sjukdom]].<ref name="ICC2011primer" /><ref name="CDC-causes" /> ME för med sig symptom i [[sv:Centrala nervsystemet\|centrala nervsystemet]] (CNS), [[sv:Autonoma nervsystemet\|autonoma nervsystemet]] (ANS), [[immune system\|immunsystemet]], [[~~cardiovascular system~~\|kardiovaskulära systemet]], [[endocrine system\|endokrina systemet]], [[digestive system\|matsmältningssystemet]], och [[musculoskeletal system\|muskuloskeletala systemet]].<ref name="ICC2011primer" /><ref name="CDC-symptoms" />		'''Myalgisk encefalomyelit''' (ME) är en kronisk, [[sv:Inflammation\|inflammatorisk]], fysisk och [[sv:Nervsystem\|neurologisk]] och immun-förmedlad sjukdom med symptom som involverar många kroppssystem. Den blir ofta utlöst av en [[sv:Virusinfektion\|virusinfektion]] eller en [[sv:Influensaliknande sjukdom\|influensaliknande sjukdom]].<ref name="ICC2011primer" /><ref name="CDC-causes" /> ME för med sig symptom i [[sv:Centrala nervsystemet\|centrala nervsystemet]] (CNS), [[sv:Autonoma nervsystemet\|autonoma nervsystemet]] (ANS), [[immune system\|immunsystemet]], [[sv:Kardiovaskulära systemet\|kardiovaskulära systemet]], [[endocrine system\|endokrina systemet]], [[digestive system\|matsmältningssystemet]], och [[musculoskeletal system\|muskuloskeletala systemet]].<ref name="ICC2011primer" /><ref name="CDC-symptoms" />

	Myalgisk encefalomyelit klassades först som en [[sv:nervsystem\|neurologisk]] sjukdom av [[World Health Organization\|Världshälsoorganisationen]] (WHO) 1969 med publiceringen av [[World Health Organization#icd8\|Världshälsoorganisationens ICD-8]] manual.<ref name="ICD-8">{{Cite book \|url=https://apps.who.int/iris/bitstream/handle/10665/70934/ICD_10_1969_eng_v2a.pdf \| title=Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death Based on the Recommendations of the Eighth Revision Conference \| last = World Health Organization \| first = \| authorlink = World Health Organization\|publisher=WHO\| year = 1969\|isbn=\|editor-link=\|edition=8th\|volume=2\|location=Geneva \| page = 173\|chapter=\|quote=Encephalomyelitis (chronic),<br>(myalgic, benign) 323}}</ref>		Myalgisk encefalomyelit klassades först som en [[sv:nervsystem\|neurologisk]] sjukdom av [[World Health Organization\|Världshälsoorganisationen]] (WHO) 1969 med publiceringen av [[World Health Organization#icd8\|Världshälsoorganisationens ICD-8]] manual.<ref name="ICD-8">{{Cite book \|url=https://apps.who.int/iris/bitstream/handle/10665/70934/ICD_10_1969_eng_v2a.pdf \| title=Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death Based on the Recommendations of the Eighth Revision Conference \| last = World Health Organization \| first = \| authorlink = World Health Organization\|publisher=WHO\| year = 1969\|isbn=\|editor-link=\|edition=8th\|volume=2\|location=Geneva \| page = 173\|chapter=\|quote=Encephalomyelitis (chronic),<br>(myalgic, benign) 323}}</ref>

← Older revision		Revision as of 23:47, November 12, 2026
Line 10:		Line 10:
	En [[Netherlands\|Nederländsk]] studie 2016 var först med att använda kontrastförstärkt kardiell magnetresonanstomografi (CMR) för att utvärdera hjärtengagemang i kvinnor med CFS. Tolv kvinnor som hade en CDS-diagnos baserad på [[Fukuda criteria\|Fukudakriterierna]] rekryterades från ett specialiserat CFS-center. Trettiosex kontroller som hade matchande ålder och kön inkluderades också. Slutsatserna var att kardiell magnetresonanstomografi visade att patienter med CFS har mindre dimension på den nedre vänstra ventrikeln och lätt nedsatt funktion av den vänstra ventrikeln. Abnormaliteter i rörelsen av hjärtats väggar och närvaron av myokardiell fibros observerades i vissa CFS-patienter.<ref name="Olimulder, 2016" />		En [[Netherlands\|Nederländsk]] studie 2016 var först med att använda kontrastförstärkt kardiell magnetresonanstomografi (CMR) för att utvärdera hjärtengagemang i kvinnor med CFS. Tolv kvinnor som hade en CDS-diagnos baserad på [[Fukuda criteria\|Fukudakriterierna]] rekryterades från ett specialiserat CFS-center. Trettiosex kontroller som hade matchande ålder och kön inkluderades också. Slutsatserna var att kardiell magnetresonanstomografi visade att patienter med CFS har mindre dimension på den nedre vänstra ventrikeln och lätt nedsatt funktion av den vänstra ventrikeln. Abnormaliteter i rörelsen av hjärtats väggar och närvaron av myokardiell fibros observerades i vissa CFS-patienter.<ref name="Olimulder, 2016" />

	Minskad hjärtvolym har associerats med blodvolym, men inte med sjukdomens varaktighet.<ref name=":0">{{Cite journal \| last = Blamire \| first = Andrew M. \| authorlink = Andrew Blamire \| last2 = MacGowan \| first2 = Guy \| authorlink2 = Guy ~~McGowan~~ \| last3 = Maclachlan \| first3 = Laura \| authorlink3 = Laura Maclachlan \| last4 = Hodgson \| first4 = Tim \| authorlink4 = Tim Hodgson \| last5 = Frith \| first5 = James \| authorlink5 = James Frith \| last6 = Petrides \| first6 = George \| authorlink6 = George Petrides \| last7 = Finkelmeyer \| first7 = Andreas \| authorlink7 = Andreas Finkelmeyer \| last8 = Newton \| first8 = Julia L. \| authorlink8 = Julia Newton \| date = 2016-06-01 \| title = Reduced cardiac volumes in chronic fatigue syndrome associate with plasma volume but not length of disease: a cohort study \| url = https://openheart.bmj.com/content/3/1/e000381 \| journal = Open Heart\|language=en \| volume = 3 \| issue = 1\| pages = e000381\|doi=10.1136/openhrt-2015-000381\|issn=2053-3624}}</ref>		Minskad hjärtvolym har associerats med blodvolym, men inte med sjukdomens varaktighet.<ref name=":0">{{Cite journal \| last = Blamire \| first = Andrew M. \| authorlink = Andrew Blamire \| last2 = MacGowan \| first2 = Guy \| authorlink2 = Guy MacGowan \| last3 = Maclachlan \| first3 = Laura \| authorlink3 = Laura Maclachlan \| last4 = Hodgson \| first4 = Tim \| authorlink4 = Tim Hodgson \| last5 = Frith \| first5 = James \| authorlink5 = James Frith \| last6 = Petrides \| first6 = George \| authorlink6 = George Petrides \| last7 = Finkelmeyer \| first7 = Andreas \| authorlink7 = Andreas Finkelmeyer \| last8 = Newton \| first8 = Julia L. \| authorlink8 = Julia Newton \| date = 2016-06-01 \| title = Reduced cardiac volumes in chronic fatigue syndrome associate with plasma volume but not length of disease: a cohort study \| url = https://openheart.bmj.com/content/3/1/e000381 \| journal = Open Heart\|language=en \| volume = 3 \| issue = 1\| pages = e000381\|doi=10.1136/openhrt-2015-000381\|issn=2053-3624}}</ref>

	En studie fann att blodvolym är starkt fysiologiskt relaterat till den högsta syrekonsumptionen i CFS-patienter.<ref name=":1">{{Cite journal \| last = Farquhar \| first = William B. \| authorlink = William Farquhar \| last2 = Hunt \| first2 = Brian E. \| authorlink2 = Brian Hunt \| last3 = Taylor \| first3 = J. Andrew \| authorlink3 = Andrew Taylor \| last4 = Darling \| first4 = Stephen E. \| authorlink4 = Stephen Darling \| last5 = Freeman \| first5 = Roy \| authorlink5 = Roy Freeman \| date = 2002-01-01 \| title = Blood volume and its relation to peak O2consumption and physical activity in patients with chronic fatigue \| url =https://www.physiology.org/doi/full/10.1152/ajpheart.2002.282.1.h66 \| journal = American Journal of Physiology-Heart and Circulatory Physiology \| volume = 282 \| issue = 1\| pages=H66–H71\|doi=10.1152/ajpheart.2002.282.1.H66\|issn=0363-6135}}</ref>		En studie fann att blodvolym är starkt fysiologiskt relaterat till den högsta syrekonsumptionen i CFS-patienter.<ref name=":1">{{Cite journal \| last = Farquhar \| first = William B. \| authorlink = William Farquhar \| last2 = Hunt \| first2 = Brian E. \| authorlink2 = Brian Hunt \| last3 = Taylor \| first3 = J. Andrew \| authorlink3 = Andrew Taylor \| last4 = Darling \| first4 = Stephen E. \| authorlink4 = Stephen Darling \| last5 = Freeman \| first5 = Roy \| authorlink5 = Roy Freeman \| date = 2002-01-01 \| title = Blood volume and its relation to peak O2consumption and physical activity in patients with chronic fatigue \| url =https://www.physiology.org/doi/full/10.1152/ajpheart.2002.282.1.h66 \| journal = American Journal of Physiology-Heart and Circulatory Physiology \| volume = 282 \| issue = 1\| pages=H66–H71\|doi=10.1152/ajpheart.2002.282.1.H66\|issn=0363-6135}}</ref>